<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Inflamm Res</journal-id>
<journal-id journal-id-type="iso-abbrev">J Inflamm Res</journal-id>
<journal-id journal-id-type="publisher-id">jir</journal-id>
<journal-id journal-id-type="pmc">jinres</journal-id>
<journal-title-group>
<journal-title>Journal of Inflammation Research</journal-title>
</journal-title-group>
<issn pub-type="epub">1178-7031</issn>
<publisher>
<publisher-name>Dove</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32801832</article-id>
<article-id pub-id-type="pmc">7406375</article-id>
<article-id pub-id-type="publisher-id">258839</article-id>
<article-id pub-id-type="doi">10.2147/JIR.S258839</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Microbial Modulation of Coagulation Disorders in Venous Thromboembolism</article-title>
<alt-title alt-title-type="running-authors">Lichota et al</alt-title>
<alt-title alt-title-type="running-title">Lichota et al</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-5399-3144</contrib-id>
<name>
<surname>Lichota</surname>
<given-names>Anna</given-names>
</name>
<xref ref-type="aff" rid="aff0001">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="an0001"></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-2590-7496</contrib-id>
<name>
<surname>Gwozdzinski</surname>
<given-names>Krzysztof</given-names>
</name>
<xref ref-type="aff" rid="aff0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-7148-4063</contrib-id>
<name>
<surname>Szewczyk</surname>
<given-names>Eligia M</given-names>
</name>
<xref ref-type="aff" rid="aff0001">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff0001"><label>1</label>Department of Pharmaceutical Microbiology and Microbiological Diagnostics, Faculty of Pharmacy, <institution>Medical University of Lodz</institution>, <addr-line>Lodz</addr-line>, <country>Poland</country></aff>
<aff id="aff0002"><label>2</label>Department of Molecular Biophysics, Faculty of Biology and Environmental Protection, <institution>University of Lodz</institution>, <addr-line>Lodz</addr-line>, <country>Poland</country></aff>
</contrib-group>
<author-notes>
<corresp id="an0001">Correspondence: Anna Lichota Department of Pharmaceutical Microbiology and Microbiological Diagnostics, Faculty of Pharmacy, <institution>Medical University of Lodz</institution>, <addr-line>Pomorska 137</addr-line>, <addr-line>Lodz</addr-line><addr-line>90-235</addr-line>, <country>Poland</country><phone>Tel +48 426779300</phone> Email anna.lichota@umed.lodz.pl</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>7</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>13</volume>
<fpage>387</fpage>
<lpage>400</lpage>
<history>
<date date-type="received">
<day>18</day>
<month>4</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>6</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© 2020 Lichota et al.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>Lichota et al.</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
<license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<title>Abstract</title>
<p>Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third leading cause of cardiovascular death in the world. Important risk factors of thrombosis include bed restraint, surgery, major trauma, long journeys, inflammation, pregnancy, and oral contraceptives, previous venous thromboembolism, cancer, and bacterial infections. Sepsis increases the risk of blood clot formation 2–20 times. In this review, we discussed various mechanisms related to the role of bacteria in venous thrombosis also taking into consideration the role of the human microbiome. Many known bacteria, such as <italic>Helicobacter pylori, Chlamydia pneumoniae, Mycoplasma pneumoniae, Haemophilus influenzae, Streptococcus pneumoniae, Staphylococcus aureus</italic>, and <italic>Escherichia coli</italic>, causing infections may increase the risk of thrombotic complications through platelet activation or may lead to an inflammatory reaction involving the fibrinolytic system. Additionally, the bacteria participate in the production of factors causing or increasing the risk of cardiovascular diseases. An example can be trimethylamine N-oxide (TMAO) but also uremic toxins (indoxyl sulfate), short-chain fatty acids (SCFA) phytoestrogens, and bile acids. Finally, we presented the involvement of many bacteria in the development of venous thromboembolism and other cardiovascular diseases.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>sepsis</kwd>
<kwd>microbiome</kwd>
<kwd>inflammation</kwd>
<kwd>deep vein thrombosis</kwd>
<kwd>trimethylamine N-oxide</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>Medical University of Lodz</institution>
<institution-id institution-id-type="open-funder-registry">10.13039/501100005888</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>University of Lodz</institution>
<institution-id institution-id-type="open-funder-registry">10.13039/501100005643</institution-id>
</institution-wrap>
</funding-source>
</award-group>
<funding-statement>Medical University of Lodz &amp; University of Lodz.</funding-statement>
</funding-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="2"></table-count>
<ref-count count="129"></ref-count>
<page-count count="14"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s0001" sec-type="intro">
<title>Introduction</title>
<p>According to the Virchow hypothesis, blood clot formation is affected by slow blood flow, an impaired balance between hemostasis and the coagulation process (hypercoagulation), and endothelium damage. Additionally, leukocytes, platelets, tissue factor-positive microvesicles, neutrophil extracellular traps (NETs) and factors XI and XII participate in clot formation.<xref ref-type="bibr" rid="cit0001">1</xref> Factors that provoke thrombosis can be long-term immobilization caused by illness or surgery (especially orthopedic), long hours of plane flight, long driving without stops, excessive coagulation, high hematocrit, and cancer. For women, the use of oral contraceptives and pregnancy are additional risk factors.<xref ref-type="bibr" rid="cit0002">2</xref>,<xref ref-type="bibr" rid="cit0003">3</xref></p>
<p>Other risk factor is sepsis, which is a serious epidemiological and therapeutic problem, mainly at intensive care units.<xref ref-type="bibr" rid="cit0004">4</xref> The causes of sepsis include intra-abdominal infections, pneumonia, meningitis, and urinary tract infections. It can also occur in people with low immunity. Pathogens that promote sepsis and are involved in the development of thrombosis include both gram-positive (<italic>Staphylococcus aureus, Streptococcus pyogenes</italic>) and gram-negative bacteria (<italic>Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Chlamydia pneumoniae, Helicobacter pylori, Haemophilus influenzae</italic>).<xref ref-type="bibr" rid="cit0005">5</xref></p>
<p>The result of sepsis caused by gram-negative bacteria is endotoxemia, ie the appearance of released lipopolysaccharide (LPS, endotoxin) in the host’s blood. The consequence of endotoxemia is the septic shock, one key element of which is intravascular coagulation.<xref ref-type="bibr" rid="cit0006">6</xref> It was demonstrated that fully bacterial LPS has a direct and primary role in inducing significant changes in the structure of fibrin fibers. It was also proven that LPS binds directly to fibrinogen. It was found that a small amount of LPS significantly affects fibrinogen and the coagulation process, which may indicate the involvement of a very small number of inactive bacteria in inducing inflammation and disease progression.<xref ref-type="bibr" rid="cit0007">7</xref></p>
<p>As the studies of Patrakka et al<xref ref-type="bibr" rid="cit0008">8</xref> show, streptococci participate in infective endocarditis and have thrombotic properties. An important evidence for bacteria association with these diseases was the detection of deoxyribonucleic acid (DNA) in the coronary thrombosis aspirates of myocardial infarction and cerebral aneurysms. Hence, it has been proven that chronic infections can lead to a coronary artery disease and ischemic stroke.</p>
<p>Although thrombosis is often associated with an infection, the mechanisms that lead to its formation are relatively poorly understood. In this paper, we discussed the effect of bacteria/sepsis on the induction of thrombosis. We presented the various mechanisms involved in the participation of bacteria in venous thrombosis. The human microbiome and the presence of bacteria in blood vessels were also described. Then, we discussed the phenomenon of thrombosis and the frequency of its occurrence. Also, we presented the mechanisms of thrombosis induced by <italic>Staphylococcus aureus</italic> and other bacteria directly affecting the coagulation process.<xref ref-type="bibr" rid="cit0009">9</xref> We further showed the possibilities of bacteria binding to platelets and their activation. Then, we described the intestinal microbiome and the participation of its various bacteria in cardiovascular diseases. Finally, we presented the involvement of many bacteria in the development of cardiovascular diseases including thrombosis.</p>
</sec>
<sec id="s0002">
<title>Epidemiology and Risk Factors</title>
<p>The incidence of venous thromboembolism (VTE) is difficult to assess because it often has an asymptomatic course.<xref ref-type="bibr" rid="cit0010">10</xref> Sometimes, it is misdiagnosed and unrecognized even after the patient’s death due to the lack of routine post-mortem examinations.<xref ref-type="bibr" rid="cit0011">11</xref> VTE is the third cardiovascular cause of death after myocardial infarction and stroke, and increases steeply with age.<xref ref-type="bibr" rid="cit0012">12</xref> It is estimated that almost two-thirds of VTE cases are related to deep vein thrombosis (DVT), and 80% are proximal.<xref ref-type="bibr" rid="cit0013">13</xref> In the European population, there are about 70–140 DVT cases per 100 000 people a year.<xref ref-type="bibr" rid="cit0014">14</xref></p>
<p>Thrombosis or VTE in more than 90% of cases refers to the limbs, especially to the vein of the leg and concerns deep veins, because approx. 90% of venous blood flows in the deep venous system of the lower extremities. Thrombosis may also occur in superficial veins, but it may also occur in other veins, such as liver veins.<xref ref-type="bibr" rid="cit0015">15</xref> All cases of thrombosis require immediate medical intervention, especially pulmonary embolism (PE), which is directly life-threatening. From the clot formed, small clots can detach and can be transported to the right ventricle of the heart and from there to the lungs.<xref ref-type="bibr" rid="cit0013">13</xref></p>
<p>VTE is a common in patients undergoing major surgeries such as hip or knee arthroplasty, and abdominal cancer surgery. It was shown that the cause of thrombosis were the implanted vascular stents.<xref ref-type="bibr" rid="cit0016">16</xref> Release of IL-6, IL-8 and tumor necrosis factor alfa (TNF-α) cytokines is a response to systemic inflammation which leads to an increased risk of thrombosis.<xref ref-type="bibr" rid="cit0017">17</xref> It is believed that systemic infections increase the risk of deep vein thrombosis/pulmonary embolism about 2–20 times.<xref ref-type="bibr" rid="cit0005">5</xref> An additional risk factor for VTE is the age of the patients, the presence of malignant tumors, and hereditary features.<xref ref-type="bibr" rid="cit0003">3</xref> It is also known that the formation of blood clots in vessels occurs during sepsis, which indicates the participation of bacteria in this process. The factors that influence the occurrence of thrombosis have been presented. However, there are also those on which we have a direct impact including: sedentary lifestyle, obesity, smoking, long journeys by car, train or bus for 4 or more hours.</p>
</sec>
<sec id="s0003">
<title>Bacteria Forming the Human Microbiome in Blood Vessels</title>
<p>Results obtained in the Human Microbiome Project revealed a great number of bacteria, viruses, fungi, and archaea inhabiting human body.<xref ref-type="bibr" rid="cit0018">18</xref> According to a recent study, there are over 3.8 х 10<sup>13</sup> microorganisms living in different body sites.<xref ref-type="bibr" rid="cit0019">19</xref> The nature of the host-microbial interaction is complex and has a profound impact on human health.<xref ref-type="bibr" rid="cit0020">20</xref> This is a challenge taken up by vast research conducted according to metagenomic and metabolomic protocols after the introduction of the next-generation sequencing (NGS) and whole metagenome shotgun (WMGS) sequencing. Dysbiosis, understood as a perturbation in microbiome composition, has been regarded as associated with numerous diseases including arteriosclerosis and thromboembolism.<xref ref-type="bibr" rid="cit0021">21</xref>,<xref ref-type="bibr" rid="cit0022">22</xref> Microbial communities were found in the mouth, lung, gut, and vagina of healthy humans. Most frequently identified bacterial and fungal genera are presented in <xref ref-type="table" rid="t0001">Table 1</xref>.<xref ref-type="bibr" rid="cit0023">23</xref><table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1</label><caption><p>Diversity of Bacteria and Fungi Inhabiting Human Body</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Human Body</th><th colspan="1" rowspan="1">Bacterial Genera</th><th colspan="1" rowspan="1">Fungal Genera</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Mouth</td><td colspan="1" rowspan="1"><italic>Actinomyces</italic><break></break><italic>Fusobacterium</italic><break></break><italic>Gemella</italic><break></break><italic>Granulicatella</italic><break></break><italic>Neisseria</italic><break></break><italic>Rothia</italic><break></break><italic>Streptococcus</italic><break></break><italic>Veillonella</italic></td><td colspan="1" rowspan="1"><italic>Aspergillus</italic><break></break><italic>Aureobasidium</italic><break></break><italic>Candida</italic><break></break><italic>Cladosporium</italic><break></break><italic>Cryptococcus</italic><break></break><italic>Fusarium</italic><break></break><italic>Malassezia</italic></td></tr><tr><td colspan="1" rowspan="1">Lung</td><td colspan="1" rowspan="1"><italic>Fusobacterium</italic><break></break><italic>Haemophilus</italic><break></break><italic>Neisseria</italic><break></break><italic>Prevotella</italic><break></break><italic>Streptococcus</italic></td><td colspan="1" rowspan="1"><italic>Aspergillus</italic><break></break><italic>Candida</italic><break></break><italic>Cladosporium</italic><break></break><italic>Clavispora</italic><break></break><italic>Davidiellaceae</italic></td></tr><tr><td colspan="1" rowspan="1">Gut</td><td colspan="1" rowspan="1"><italic>Bacteroides</italic><break></break><italic>Bifidobacterium</italic><break></break><italic>Clostridium</italic><break></break><italic>Enterobacter</italic><break></break><italic>Eubacterium</italic><break></break><italic>Lactobacillus</italic><break></break><italic>Methanobacterium</italic><break></break><italic>Prevotella</italic><break></break><italic>Streptococcus</italic><break></break><italic>Veillonella</italic><break></break><italic>Verrucomicrobia</italic></td><td colspan="1" rowspan="1"><italic>Candida</italic><break></break><italic>Cladosporium</italic><break></break><italic>Debaryomyces</italic><break></break><italic>Fusarium</italic><break></break><italic>Malassezia</italic><break></break><italic>Pichia</italic><break></break><italic>Saccharomyces</italic></td></tr><tr><td colspan="1" rowspan="1">Vagina</td><td colspan="1" rowspan="1"><italic>Atopobium</italic><break></break><italic>Escherichia</italic><break></break><italic>Gardnerella</italic><break></break><italic>Lactobacillus</italic><break></break><italic>Mycoplasma</italic><break></break><italic>Prevotella</italic><break></break><italic>Staphylococcus</italic><break></break><italic>Streptococcus</italic><break></break><italic>Ureaplasma</italic></td><td colspan="1" rowspan="1"><italic>Candida</italic><break></break><italic>Cladosporium</italic><break></break><italic>Davidiellaceae</italic><break></break><italic>Pichia</italic><break></break><italic>Saccharomyces</italic></td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><bold>Notes:</bold> Information in the table based on the analysis of documents: Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Medicine. 2016;8(1):51<xref ref-type="bibr" rid="cit0020">20</xref> and Krüger W, Vielreicher S, Kapitan M, Jacobsen ID, Niemiec MJ. Fungal-Bacterial Interactions in Health and Disease. Pathogens. 2019;8(2):70.<xref ref-type="bibr" rid="cit0023">23</xref></p></fn></table-wrap-foot></table-wrap>
</p>
<p>Until recently, blood circulating in healthy human bodies has been considered as sterile. The presence of bacteria in the bloodstream was always considered as bacteremia and the concept of blood microbiome has been met with criticism. Although we should approach it with some reservations, the presence of microorganisms in the blood of healthy individuals has been confirmed by different contemporary methods. The number of studies revealing the presence of blood microbiome assessed by metagenomic sequencing increases.<xref ref-type="bibr" rid="cit0024">24</xref>–<xref ref-type="bibr" rid="cit0026">26</xref> However, it is still unknown whether the bacteria there are stable or transient residents. In any case, their role in thromboembolism must be carefully considered. The ways for the bacteria to enter into the circulatory system are being considered. The presence of <italic>Proteobacteria, Actinobacteria, Firmicutes</italic>, and <italic>Bacteroidetes</italic> in blood is probably a consequence of their translocation from the intestinal tract.<xref ref-type="bibr" rid="cit0026">26</xref> In their studies, Qiu and colleagues<xref ref-type="bibr" rid="cit0027">27</xref> concluded that the presence of blood type <italic>Bacteroides</italic> caused a reduced risk of diabetes. It is also suggested that their presence could potentially trigger other not-communicable, inflammatory diseases including metabolic and hematological disorders.<xref ref-type="bibr" rid="cit0028">28</xref>
<italic>Bacteroidetes</italic> members originating from the oral microbiome like <italic>Porphyromonas gingivalis</italic> have been implicated in the development of atherosclerosis.<xref ref-type="bibr" rid="cit0029">29</xref> Other studies indicated that intraplaque hemorrhage present in the samples of carotid thrombosis is associated with increased neutrophil activation markers, nuclear factor kappa B (NF-κB) activity, and LPS – part of the outer membrane of the present periodontal bacteria: <italic>Porhyromonas gingivalis</italic> and <italic>Tannerella forsythia</italic>.<xref ref-type="bibr" rid="cit0030">30</xref> A functional role of the bacteria in thrombus growth in carotid artery was shown also in lipoprotein receptor-deficient mice.<xref ref-type="bibr" rid="cit0031">31</xref></p>
<p>The functioning of the coagulation system is associated with the repair of damaged blood vessels and coagulation activation process. The coagulation is a response to the damage to blood vessels consisting in forming fibrin, whose main function is to seal the vessel and stop the bleeding. This process aims to bind the bacteria in a blood clot to prevent them from spreading. On the other hand, coagulation factors can bind bacteria in clots preventing immune system’s actions and support their survival in the host organisms. It is known that infection increases the risk of thrombosis, but it has also been shown that the infection itself can also lead to thrombotic events.<xref ref-type="bibr" rid="cit0032">32</xref>–<xref ref-type="bibr" rid="cit0034">34</xref></p>
<p>There are two pathways to the cascade of proteins in plasma that have an important role in host defense and hemostasis.<xref ref-type="bibr" rid="cit0035">35</xref> These include the complement and coagulation systems. Complement activation on bacteria provokes their killing through the membrane attack complex (MAC); additionally, small antibacterial peptides can be released.<xref ref-type="bibr" rid="cit0036">36</xref> Host defense associated with complement activation on bacteria helps the cellular immune response and leads to direct killing of the bacteria. Blood clotting is also thought to be an innate immune response, as it helps trigger the inflammatory response, generates and releases antimicrobial peptides, and immobilizes bacteria in clots.<xref ref-type="bibr" rid="cit0037">37</xref>,<xref ref-type="bibr" rid="cit0038">38</xref></p>
<p>Additionally, microbes cause an inflammatory response in which the fibrinolytic system is involved.<xref ref-type="bibr" rid="cit0039">39</xref> The key role in this process is held by plasminogen, which is transformed into plasmin with the participation of host physiological activators, ie urokinase plasminogen activator (u-PA) or tissue plasminogen activator (t-PA). Plasminogen activation to plasmin may also occur with the participation of bacterial plasminogen activators such as streptokinase (SK).<xref ref-type="bibr" rid="cit0040">40</xref>,<xref ref-type="bibr" rid="cit0041">41</xref></p>
<p>The bacterial infection leads to large changes in the balance between coagulation and fibrinolysis.<xref ref-type="bibr" rid="cit0042">42</xref> Some bacteria use the host’s hemostatic system to bypass the immune defense. Examples are <italic>Yersinia pestis</italic>, streptococci from Lancefield groups A, C, G, and <italic>Staphylococcus aureus</italic>. Bacteria produce a specific bacterial plasminogen activator which converts plasminogen to plasmin (<xref ref-type="fig" rid="f0001">Figure 1</xref>).<xref ref-type="bibr" rid="cit0043">43</xref> This section discussed a review of the various bacteria present in the human body and their involvement in diseases and binding them through the coagulation system.<fig fig-type="figure" id="f0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Use of plasminogen by bacteria for the production of plasmin, serine protease by bacterial SK or by host plasminogen activators eg u-PA and t-PA, which is released from ECs. The formed plasmin participates in the degradation of fibrin clot as well as laminin, fibronectin and type IV collagen and other components of ECM, which leads to the spread of bacteria through tissue barriers.</p><p><bold>Abbreviations:</bold> SK, streptokinase; u-PA, urokinase plasminogen activator; t-PA, tissue plasminogen activator; ECs, endothelial cells; ECM, extracellular matrix.</p></caption><graphic content-type="print-only" xlink:href="JIR-13-387-g0001"></graphic></fig></p>
</sec>
<sec id="s0004">
<title>Correlation of Oxidative Stress and Infections</title>
<p>Many studies have shown that inflammatory, immunological, hormonal, and metabolic reactions are involved in the pathogenesis of sepsis.<xref ref-type="bibr" rid="cit0044">44</xref> The main factor in these processes is the imbalance between the generation of reactive oxygen species (ROS) and their removal, which in consequence leads to oxidative stress.<xref ref-type="bibr" rid="cit0045">45</xref> The relationship between infection and the production of ROS has been clearly shown in numerous works.<xref ref-type="bibr" rid="cit0046">46</xref> The generation of ROS is believed to be associated at least in part with bacterial-induced metabolic pathways, and oxidative stress is involved in organ damage and cancer development.<xref ref-type="bibr" rid="cit0047">47</xref> It has been shown that <italic>Helicobacter pylori</italic> induces the enzymes that produce ROS, for example, spermine oxidase, and regulates pro-inflammatory and pro-cancerogenic genes such as cyclooxygenase 2 (COX-2).<xref ref-type="bibr" rid="cit0048">48</xref></p>
<p>Chemical stimulation of cells by cytokines, xenobiotics, and bacterial invasion leads to ROS generation.<xref ref-type="bibr" rid="cit0049">49</xref> Numerous experimental and clinical studies confirm the key role of ROS in the mechanism of platelet activation. There are many activation pathways, one of which is an increased isoprostane formation.<xref ref-type="bibr" rid="cit0050">50</xref> Another source is arachidonic acid metabolism and associated lipoxygenase expression, the other is NADPH oxidase (NOX).<xref ref-type="bibr" rid="cit0051">51</xref> On the one hand, platelet can be modified by ROS, on the other, they generate ROS. ROS are formed within activated platelets and regulate their responses to collagen-mediated thrombus formation.<xref ref-type="bibr" rid="cit0050">50</xref></p>
<p>Recently, it has been shown that acetylcholinesterase (AChE) and catalase activity decreased in the neuromuscular junction (NMJ) of the diaphragm during sepsis. Their activity was significantly negatively correlated with the level of thiobarbituric acid reactive substances (TBARS) and the level of carbonyl compounds that appear during oxidative damage to proteins. The obtained results clearly showed that during sepsis, oxidative stress occurs, which damages the biological material.<xref ref-type="bibr" rid="cit0052">52</xref></p>
<p>Excessive release of ROS also occurs in hypoxia. Although the exact mechanism of ROS release in hypoxia is still under discussion, it seems that their generation is related to the mitochondrial electron transport chain (ETC). ROS are generated by complexes I, II and III of the endothelial cells (ECs).<xref ref-type="bibr" rid="cit0053">53</xref>,<xref ref-type="bibr" rid="cit0054">54</xref></p>
<p>In hypoxia or low oxygen levels, the organism induces hypoxia-inducible factor (HIF)-1, which is a heterodimer and regulates the expression of over 100 genes.<xref ref-type="bibr" rid="cit0055">55</xref> HIF-1 is also necessary for the immune response and is an important physiological regulator of homeostasis and anaerobic metabolism. In addition, HIF-1 may interact with enzymes and other transcription factors leading to angiogenesis and tissue growth.<xref ref-type="bibr" rid="cit0056">56</xref>,<xref ref-type="bibr" rid="cit0057">57</xref> Hypoxia is known for deep vein thrombosis and venous thromboembolism and is a consequence of phenotypic changes in venous endothelial cells associated with activation of the elk-1/egr-1 pathway and increased expression of TF.<xref ref-type="bibr" rid="cit0058">58</xref> The thrombotic S protein, which is inversely regulated by HIF-1, have an important role in thrombosis. This important finding explains the mechanism of thrombosis in hypoxia.<xref ref-type="bibr" rid="cit0059">59</xref>
<italic>Bartonella henselae</italic> is the only known bacterium that leads to vasculoproliferative disorders in humans. <italic>Bartonella henselae</italic> infection resulted in increased oxygen consumption in the host cells, causing cell hypoxia and a decrease in adenosine triphosphate (ATP) levels. This pathogen has been shown to trigger a pro-angiogenic host cell response via HIF-1, which is evidence that HIF-1 may have a role in bacterial infections.<xref ref-type="bibr" rid="cit0060">60</xref> Excessive release of ROS leads to damage to biological material and is a consequence of modification of metabolic pathways by bacteria.</p>
</sec>
<sec id="s0005">
<title>Interaction of Platelets with Bacteria</title>
<p>Blood platelets are sensitive to factors from the surrounding environment due to receptors present on their surface and they interact with each other and with other cells. Platelets have a key role in cardiovascular diseases such as thrombosis, myocardial infarction, stroke.<xref ref-type="bibr" rid="cit0061">61</xref></p>
<p>The increase in platelet activation may also be associated with a decrease in the release or/and inactivation of nitric oxide and the release of platelet agonists. Substances released from platelets, such as ROS, including nitric oxide, cytokines, growth factors, chemokines, metalloproteinases, histamine, and selectin, are involved in the immune response and inflammatory reactions.<xref ref-type="bibr" rid="cit0062">62</xref> Platelet may release antibacterial molecules and can induce apoptosis (phosphatidylserine exposure, caspase 3 activation, and depolarization of mitochondrial potential).<xref ref-type="bibr" rid="cit0009">9</xref>,<xref ref-type="bibr" rid="cit0063">63</xref></p>
<p>Platelets can interact with bacteria through three mechanisms: direct binding of bacteria to a platelet receptor, indirect binding via fibrinogen, fibronectin, first complement C1q, von Willebrand factor (vWF), and binding of secreted bacterial products, mainly toxins (<xref ref-type="fig" rid="f0002">Figure 2</xref>).<xref ref-type="bibr" rid="cit0009">9</xref> Bacteria can attach to platelet via a direct interaction with GPIIb-IIIa or via an indirect interaction with GPIIb-IIIa. <italic>Staphylococcus aureus</italic> can bind to platelets directly by fibrinogen and/or fibronectin, which are ligands for GPIIb-IIIa and/or via a short amino acid sequence, arginyl glycyl aspartic acid.<xref ref-type="bibr" rid="cit0064">64</xref> Protein A exposed on the surface of bacteria <italic>Staphylococcus aureus</italic> can attach to the FcγRII receptor exposed on the surface of platelet membrane and can lead to the release of serotonin and platelet aggregation. Both FcγRII, required for <italic>Staphylococcus aureus</italic> adhesion, and aggregation induced by these bacteria depend on FcγRII, which activates GPIIb-IIIa functions.<xref ref-type="bibr" rid="cit0065">65</xref> In turn, <italic>Streptococcus sanguinis</italic> can directly affect GPIbα and vWF receptors on the platelet surface.<xref ref-type="bibr" rid="cit0066">66</xref>
<italic>Helicobacter pylori</italic> can also bind to a platelet using the vWF and GPIbα receptors.<xref ref-type="bibr" rid="cit0067">67</xref> However, in binding to platelet, bacteria most often use an IgG molecule that interacts with the FcγRIIa platelet receptor.<xref ref-type="bibr" rid="cit0064">64</xref><fig fig-type="figure" id="f0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Direct or indirect adhesion of bacteria to platelets. (<bold>A</bold>) Direct biding of bacteria via GPIIb-IIIa or GPIb (α-β) exposed on platelet surface. (<bold>B</bold>) Indirect binding of bacteria via spacer like fibrinogen or fibronectin and GPIIb-IIIa but also GPIb (α-β) via vWF. Platelets may also bind bacteria by gC1qR or/and CD62P receptors exposed on the platelet surface. Another “spacer” that binds bacteria to platelets is IgG delivered by bacteria through the FcγRIIa receptor present on platelets.</p><p><bold>Abbreviations:</bold> PL, platelets; GP, glycoprotein; vWF, von Willebrand factor; IgG, immunoglobulin G.</p></caption><graphic content-type="print-only" xlink:href="JIR-13-387-g0002"></graphic></fig></p>
<p>Binding of bacteria to platelets leads to their aggregation, as shown in the example of <italic>Streptococcus sanguinis, Staphylococcus epidermidis</italic>, or <italic>Chlamydia pneumoniae</italic>.<xref ref-type="bibr" rid="cit0009">9</xref> Many bacteria ie gram-positive bacteria <italic>Staphylococcus aureus</italic> can activate the blood clotting system and influence the individual coagulation factors, although they do not lead directly to the initiation of the coagulation cascade. Activation of the coagulation system by these bacteria protects them from being attacked by the host’s immune system.<xref ref-type="bibr" rid="cit0068">68</xref> For example, <italic>Staphylococcus aureus</italic> forms aggregates with extracellular matrix (ECM) proteins, which include fibrinogen, fibronectin, and collagen.<xref ref-type="bibr" rid="cit0069">69</xref> The formation of platelet aggregates promotes the colonization of host tissues.<xref ref-type="bibr" rid="cit0070">70</xref> Many microorganisms can use blood clotting to their advantage, <italic>Staphylococcus aureus</italic> is one of these microorganisms.<xref ref-type="bibr" rid="cit0068">68</xref> On the other hand, platelets together with neutrophils form traps for bacteria, but this, in turn, leads to an increased risk of thrombosis.<xref ref-type="bibr" rid="cit0009">9</xref></p>
<p>Further, activated platelets can also adhere to endothelial cells leading to the formation of a blood clot. EC release pro-inflammatory cytokines (IL-6, IL-8 and TNF-α) during the response to inflammation. In turn, cytokines lead to a procoagulant state, mainly through the induction of tissue factor (TF) expression, which has an important role in VTE. It was shown that an inflammatory condition promotes platelets<xref ref-type="bibr" rid="cit0017">17</xref> and platelets aggregation.<xref ref-type="bibr" rid="cit0071">71</xref></p>
<p>Bacterial toxins lead to an inhibition of platelet function, causing damage to protein kinase C (PKC). This impairs phosphorylation of vasodilator-stimulated phosphoprotein (VASP) and a loss of fibrinogen activity or fibrinogen damage.<xref ref-type="bibr" rid="cit0009">9</xref> Excessive platelet activation leads to vascular thrombosis and is associated with acute coronary syndrome and ischemic stroke.<xref ref-type="bibr" rid="cit0062">62</xref>
<italic>Escherichia coli</italic> releases Shiga-like toxin (verotoxin), which increases platelet aggregation. This toxin binds to the surface of platelets via glycosphingolipid receptors.<xref ref-type="bibr" rid="cit0072">72</xref>,<xref ref-type="bibr" rid="cit0073">73</xref> Using the intravital imaging method, it has been shown that <italic>Staphylococcus aureus</italic> toxin directly attacks platelets, leading to their aggregation in the circulation.<xref ref-type="bibr" rid="cit0074">74</xref></p>
<p>Platelets and neutrophils are necessary for the initiation and growth of thrombus. Platelets and neutrophils form NETs in thrombosis (<xref ref-type="fig" rid="f0003">Figure 3</xref>). The traps also contain other components such as extracellular DNA, proteins, histones, serine proteases, and others, which in total lead to platelet coagulation and aggregation. Additionally, peptidylarginine deiminase type 4 (PAD4), an enzyme that causes chromatin decondensation, but also controls NETs formation (NETosis) and thrombosis, promotes blood clot formation.<xref ref-type="bibr" rid="cit0075">75</xref>,<xref ref-type="bibr" rid="cit0076">76</xref> Further, NETs bacteria bind to platelets and red blood cells (RBCs) to form red thrombi. Also, it binds nucleic acids and histones that can activate coagulation. A similar effect is shown by histones, which activate platelets, increasing thrombin production, thus promoting coagulation.<xref ref-type="bibr" rid="cit0077">77</xref> Platelets have a key role in hemostasis, but are also important in bacterial-induced thrombosis.<fig fig-type="figure" id="f0003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>The formation of NETs in response to infection is associated with the interaction of platelets with neutrophils containing cathepsin, DNA and protein components such as histones and serine proteases, PAD4, elastase and others. ROS also participate in NETs formation.</p><p><bold>Abbreviations:</bold> NETs, neutrophil extracellular traps; DNA, deoxyribonucleic acid; PAD4, peptidylarginine deiminase type 4; ROS, reactive oxygen species.</p></caption><graphic content-type="print-only" xlink:href="JIR-13-387-g0003"></graphic></fig></p>
</sec>
<sec id="s0006">
<title>Gut Microbiome and Cardiovascular Diseases</title>
<p>As research has shown, the number of bacteria forming the microbiome inhabiting the human digestive tract (DT) increases with an increasing pH in subsequent sections of the DT and a reduction in oxygen concentration. It is estimated that the largest number of microorganisms is in the large intestine, and the diversity of composition reaches about 2000 species there.<xref ref-type="bibr" rid="cit0078">78</xref> The microbiome of colon consists predominantly of <italic>Bacteroidetes</italic> (with predominant <italic>Bacteroides, Prevotella</italic>, and <italic>Porphyromons</italic>) and <italic>Firmicutes</italic> with <italic>Clostridium, Bacillales</italic>, and <italic>Lactobacillales</italic> accounting for over 90% of all bacteria in that niche. <italic>Actinobacteria</italic> and <italic>Proteobacteria</italic> are the other part of this ecosystem. In the small intestinal aspirate in healthy humans, there is 10<sup>4</sup>–10<sup>7</sup> CFU/g and genera <italic>Streptococcus, Lactobacillus</italic>, and <italic>Veilonella</italic> are predominant.<xref ref-type="bibr" rid="cit0079">79</xref> Microbiome disorders lead to many pathological conditions ranging from infectious diseases to cardiovascular and metabolic disorders, gastrointestinal diseases, and neurological diseases.<xref ref-type="bibr" rid="cit0080">80</xref> A disturbance in the number and diversity of the intestinal microbiome has been associated with Crohn’s disease, irritable bowel syndrome but also, cancer, malabsorption syndrome as well as neurological and psychological diseases.<xref ref-type="bibr" rid="cit0081">81</xref>–<xref ref-type="bibr" rid="cit0084">84</xref></p>
<p>It was indicated that there is a connection between the number and composition of intestinal microbiome and thromboembolism. A known example is small intestinal bacterial overgrowth (SIBO), a malabsorption syndrome, which is referred to as an increase in the number of bacteria in the proximal part of small bowel or dysbiosis manifested as the presence of bacteria characteristic for colon. Cheng et al<xref ref-type="bibr" rid="cit0085">85</xref> showed the DVT as a dangerous complication associated with SIBO during posttraumatic hospitalization in patients after spinal cord injury. SIBO syndrome leads to increased bowel permeability with enhanced adsorption of LPS and other bacterial products.<xref ref-type="bibr" rid="cit0086">86</xref> It is suggested that testing and treatment for SIBO may be beneficial for suffering patients and may prevent deep venous thrombosis. The reason for that is not precisely known but similarly to other diseases associated with SIBO, it may be a gut inflammation state caused by bacterial products. Increased expression of pro-inflammatory cytokines as IL-1a and IL-1b and increased production of IL-8 have been shown as a result of toll-like receptor 4 (TLR-4) for LPS expression on cells.<xref ref-type="bibr" rid="cit0087">87</xref></p>
<p>Intestinal bacteria are an inseparable anatomical and physiological element of the human body. They are involved in the biosynthesis of metabolically active compounds by regulating processes in health but also have a role in the pathogenesis of diseases. Apart of LPS which is a constituent part of the cell wall of all gram-negative bacteria, gut microbiome bacteria can derive metabolites that have clinical relevance in disease pathogenesis. These are TMAO, uremic toxins, short-chain fatty acids (SCFA), phytoestrogens, anthocyanins, or bile acids. The bioactive molecules may have an important role in thrombosis as well as other cardiovascular diseases.<xref ref-type="bibr" rid="cit0088">88</xref> They can be accumulated in blood, influencing many processes. Bacteria can also act directly producing enzymes activating blood clotting factors. Many families of colon bacteria, for example <italic>Clostridiaceae, Enterobacteriaceae</italic>, can produce urease, many can produce tryptophanase (ie <italic>Clostridiaceae, Enterobacteriaceae</italic>, and <italic>Verrucomicrobiaceae</italic>) or produce short-chain fatty acids (i.e <italic>Lactobacillaceae, Bifidobacteriaceae, Prevotellaceae</italic>). Uremic toxin-indoxyl sulfate, when bound to albumin, enhances platelet activities and increases response to collagen and thrombin which in consequence leads to thrombosis.<xref ref-type="bibr" rid="cit0089">89</xref> Produced by bacteria, short-chain acids contribute to blood pressure control and phytoestrogens may have prothrombotic and intermediately triggering pro-inflammatory and anti-inflammatory action connected with TNF-α production. Anthocyanins which modulate gut microbiota and are antiplatelet agents also have an importance in cardiovascular diseases prevention.<xref ref-type="bibr" rid="cit0088">88</xref> Changes in human microbiome have a significant impact on the development of cardiovascular diseases, including thrombosis.</p>
</sec>
<sec id="s0007">
<title>TMAO and Thrombosis Risk</title>
<p>Microorganisms inhabiting the gut affect the physiology and metabolism throughout the body. It has been shown that the host-microbiome has produced various substances such as trimethylamine (TMA), short-chain fatty acids, and secondary bile acids that can affect cardiovascular disease. The modification of interaction between the host and its microflora may likely contribute to the prevention and/or treatment of cardiovascular diseases.<xref ref-type="bibr" rid="cit0090">90</xref></p>
<p>TMAO is a known metabolite in animals resulting from the oxidation of trimethylamine. TMAO is found in marine animals, such as fish, sharks, rays, mollusks, and crustaceans, including deep-sea fishes and crustaceans as a protector against high pressure, which can damage the proteins.<xref ref-type="bibr" rid="cit0091">91</xref>,<xref ref-type="bibr" rid="cit0092">92</xref> TMA of bacterial origin is oxidized to TMAO by flavin-containing monooxygenase (FMO). This enzyme is expressed in the liver and oxidizes xenobiotics containing amines or sulfides. TMAO has been identified as an independent risk factor of cardiovascular disease, as well as other disorders.<xref ref-type="bibr" rid="cit0093">93</xref>–<xref ref-type="bibr" rid="cit0095">95</xref> It was reported that TMAO enhances platelet hyperactivity and thrombosis risk.<xref ref-type="bibr" rid="cit0096">96</xref> TMA is produced by the anaerobic gram-positive <italic>Ruminococcus</italic> bacteria belonging to the <italic>Clostridia</italic> class occurring in a significant number in the human intestinal microflora.<xref ref-type="bibr" rid="cit0097">97</xref>,<xref ref-type="bibr" rid="cit0098">98</xref></p>
<p>The presented research on a group of 513 people after cardiovascular events, of which about 70% were smokers, showed high levels of TMAO in the blood.<xref ref-type="bibr" rid="cit0099">99</xref> The concentration of TMAO is also increased in the blood of people who eat food containing carnitine or lecithin.<xref ref-type="bibr" rid="cit0099">99</xref>,<xref ref-type="bibr" rid="cit0100">100</xref> Bacteria of the Acinetobacter species present in the human intestine can convert dietary carnitine into TMAO. High concentrations of carnitine are present in red meat, soy, dietary supplements, and even in energy drinks.<xref ref-type="bibr" rid="cit0100">100</xref> Patients with high TMAO plasma levels are at an increased risk of myocardial infarction or stroke.<xref ref-type="bibr" rid="cit0099">99</xref></p>
<p>In addition to TMA, the intestinal microflora also produces another toxin, indoxyl sulfate (IS). Enterobacteria, by fermentation of tryptophan, produce indole, which is hydroxylated in the liver to indoxyl by enzyme CYP250, CYP2E1, and converted to IS by sulfotransferase. In healthy individuals, IS is excreted in the urine through tubular secretion. In patients with chronic kidney disease (CKD), its concentration in plasma can be increased almost 80 times.<xref ref-type="bibr" rid="cit0101">101</xref> Thrombosis is a common complication of CKD, but the mechanism of thrombosis is not fully understood. Higher platelet activity was demonstrated in animal models that increased with the increase of serum concentration of IS leading to thrombosis.<xref ref-type="bibr" rid="cit0089">89</xref>,<xref ref-type="bibr" rid="cit0102">102</xref> TMAO and IS produced in the gut with the help of a microbiome may be an independent risk factor of cardiovascular disease.</p>
</sec>
<sec id="s0008">
<title>Clinical Aspects</title>
<p>Thrombosis may be a consequence of an improperly treated infection. However, the mechanisms associated with the induction of thrombosis by infections are poorly understood, as are the mechanisms of infection control by the host in the spread of the pathogen. Thrombosis initiated by pathogens is associated with the release of inflammatory agents activating platelets, which may be accompanied by damage to the endothelium, leading to fibrin deposition and the consequence of thrombus formation.<xref ref-type="bibr" rid="cit0005">5</xref> There are many well-known bacteria that cause infections and increase the risk of thrombotic complications, including ischemic stroke and myocardial infarction.<xref ref-type="bibr" rid="cit0103">103</xref>,<xref ref-type="bibr" rid="cit0104">104</xref> This group includes <italic>Helicobacter pylori, Chlamydia pneumoniae, Mycoplasma pneumoniae, Haemophilus influenzae, Streptococcus pneumoniae, Staphylococcus aureus, Escherichia coli</italic>, Epstein-Bar virus, herpesvirus and cytomegalovirus.<xref ref-type="bibr" rid="cit0103">103</xref>,<xref ref-type="bibr" rid="cit0105">105</xref>,<xref ref-type="bibr" rid="cit0106">106</xref></p>
<p>It was reported that ischemic stroke may occur within the first few days after respiratory or urinary tract infections, as well as in the case of chronic bronchitis.<xref ref-type="bibr" rid="cit0105">105</xref> The risk of myocardial infarction was greatly increased within 30 days.<xref ref-type="bibr" rid="cit0103">103</xref> In turn, bacteremic infections of <italic>Neisseria meningitidis</italic> and <italic>Staphylococcus aureus</italic> led to an exacerbation of cardiovascular disease such as acute myocardial infarction and unstable angina. This event is usually referred to as thrombophlebitis and can be caused by many different pathogens. This process is often referred to as thrombo-inflammation.<xref ref-type="bibr" rid="cit0107">107</xref></p>
<p>Acute respiratory or urinary tract infections lead to ischemic stroke. Many bacteria such as <italic>Helicobacter pylori, Chlamydia pneumoniae, Mycoplasma pneumoniae, Haemophilus influenzae, Streptococcus pneumoniae, Staphylococcus aureus, Escherichia coli</italic> increase the risk associated with the stroke.<xref ref-type="bibr" rid="cit0005">5</xref> It has also been reported that various cardiovascular diseases may be associated with bacterial involvement as shown on the example of infective endocarditis.<xref ref-type="bibr" rid="cit0108">108</xref></p>
<p>Relationships between pneumonia due to <italic>Haemophilus influenzae</italic> and infection with other bacteria and myocardial infarction have been confirmed. The risk of myocardial infarction was the highest at the beginning of the infection and correlated with the severity of the disease. An increased risk of myocardial infarction also occurred in urinary tract infections and bacteraemia.<xref ref-type="bibr" rid="cit0104">104</xref></p>
<p>Infections caused by <italic>Neisseria meningitidis</italic> and <italic>Staphylococcus</italic> aureus lead to exacerbations of cardiovascular disease, including acute myocardial infarction.<xref ref-type="bibr" rid="cit0109">109</xref>
<italic>Bacillus cereus</italic> and <italic>Bacillus anthracis</italic> lead to blood clotting within a few minutes in clustered bacterial cells. However, the process of blood clotting by <italic>Bacillus anthracis</italic> needed the release of the InhA1 zinc metalloprotease. This enzyme directly activated prothrombin and factor X (FX) without the factor XII (FXII) pathway or TF pathway.<xref ref-type="bibr" rid="cit0110">110</xref></p>
<p>The adhesion of bacteria to the surface of the midblock has an important role in the formation of a clot. <italic>Staphylococcus aureus</italic> bacteria release various exotoxins that, when interacting with cell membranes, lead to platelet activation and aggregation and smooth muscle contraction. Both of these factors can trigger thrombosis. In turn, the coagulase enzyme interacting with fibrinogen leads to plasma coagulation. Methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) is the most common pathogen involved in venous thrombosis with osteomyelitis. It was shown that diffuse soft tissue infection, septic arthritis, osteomyelitis and myositis can lead to deep vein thrombosis in children.<xref ref-type="bibr" rid="cit0111">111</xref>,<xref ref-type="bibr" rid="cit0112">112</xref> Vascular complications induced by MRSA were more frequent and more severe compared to methicillin-sensitive <italic>Staphylococcus aureus</italic> (MSSA) infections, especially in patients with lung involvement. MRSA infections also showed significantly higher markers of inflammation and required longer hospitalizations.<xref ref-type="bibr" rid="cit0113">113</xref></p>
<p>Because the clinical manifestations of deep musculoskeletal infections (MSI) usually overlap with DVT symptoms, the incidence of DVT as a complication of MSI may be difficult to assess. The most common infection with MSI was osteomyelitis, and the dominant pathogen was MRSA. Pulmonary involvement, probably due to septic embolism, was seen in 65% of enrolled children.<xref ref-type="bibr" rid="cit0114">114</xref></p>
<p>The gram-negative bacterium <italic>Burkholderia pseudomallei</italic> causing melioidosis has a different range of infection symptoms, with pneumonia and bacteremia being the most common presentations. However, deep vein thrombosis and PE caused by <italic>Burkholderia pseudomallei</italic> are rarely reported in the literature, but their effects can be fatal. Diabetes is an additional risk factor for DVT and PE.<xref ref-type="bibr" rid="cit0115">115</xref></p>
<p>Systemic coagulation disorders were observed not only in sepsis, but also in pneumonia. And the symptoms were associated with the activation of coagulation and inhibition of anticoagulants.<xref ref-type="bibr" rid="cit0116">116</xref> In the course of the research, it was found that bacteria or bacterial lipopolysaccharides participate in the activation of platelets and promote thrombus formation, thus complicating the clinical course of pneumonia. Platelets can interact with gram-negative and gram-positive bacteria through direct binding through the membrane surface receptors of platelets and bacterial surface protein.<xref ref-type="bibr" rid="cit0117">117</xref></p>
<p>In addition, various bacteria, including gram-positive bacteria isolated from bacteremia patients, induce platelet-neutrophil complex formation in addition to platelet activation and aggregation. Epidemiological studies have shown that pneumonia and other respiratory infections are increasing the risk of cardiovascular diseases associated with thrombosis, such as myocardial infarction, ischemic stroke, and venous thrombosis. The occurrence of myocardial infarction and stroke was observed within 48 hours of admission to hospital, with a frequency of 1% to even 11%. Additional risk factors for heart attack would be patient’s age, previous cardiovascular events, and a high rate of pneumonia. Pneumonia can also lead to DVT and PE. Lung infection is further complicated by platelet aggregation and activation of the coagulation system, which is associated with the expression of TF and down regulation of the activated C protein.<xref ref-type="bibr" rid="cit0118">118</xref></p>
<p>Purulent peripheral thrombophlebitis is not a very common occurrence but accounts for approximately 7% of cases. It can occur after the introduction of an intravenous catheter or with persistent bacteremia.<xref ref-type="bibr" rid="cit0119">119</xref>,<xref ref-type="bibr" rid="cit0120">120</xref> Its incidence is high in patients with burns, taking steroids, and in injecting drug addicts.<xref ref-type="bibr" rid="cit0121">121</xref>,<xref ref-type="bibr" rid="cit0122">122</xref> Among drug addicts, who have been using intravenous drugs for many years, DVT may appear.<xref ref-type="bibr" rid="cit0123">123</xref> A rare case of DVT in the inferior vena cava and left iliac vein in an intravenous drug user has also been described.<xref ref-type="bibr" rid="cit0124">124</xref> Drug injections alone are not a risk factor for deep vein thrombosis; however, intravenous injection of these substances is an independent risk factor.<xref ref-type="bibr" rid="cit0125">125</xref> For example, heroin triggers an increase in α-2 adrenergic receptor density platelets that can stimulate platelet aggregation dependent on adrenaline.<xref ref-type="bibr" rid="cit0126">126</xref> In contrast, opioid substances are decreasing antithrombin activity and blood viscosity due to an increase in aggregation of RBCs and platelets and a change in their deformability.<xref ref-type="bibr" rid="cit0127">127</xref>,<xref ref-type="bibr" rid="cit0128">128</xref> At the same time, an increase in fibrinogen concentration and leukocyte aggregation was observed.<xref ref-type="bibr" rid="cit0129">129</xref></p>
<p>Infections leading to pneumonia, urinary tract infections and bacteremia increase the risk of thrombotic complications such as ischemic stroke and myocardial infarction.</p>
</sec>
<sec id="s0009">
<title>Conclusion</title>
<p>Recent research results indicate a significant participation of microbes inhabiting the human body in metabolism, and thus physiology, pathophysiology, and pathogenesis of diseases. In this article, we have demonstrated that they have a direct, as well as an indirect, contribution to the development of thrombotic diseases such as ischemic stroke, myocardial infarction and VTE and PE. These processes are intensified in the course of infectious diseases, but they can also be a result of a disturbance in the composition of the microbiome, ie dysbiosis, or of microbial populations that appear transiently in the blood vessels. It is necessary to look for the relationships between these processes, especially at the metabolomic level, the explanation of which can contribute to a better diagnosis and treatment of thrombotic diseases.</p>
</sec>
</body>
<back>
<sec id="s0010">
<title>Abbreviations</title>
<p>AChE, acetylcholinesterase; ATP, adenosine triphosphate; CFU, colony forming unit; CKD, chronic kidney disease; COX, cyclooxygenase; CYP, cytochrome P; DNA, deoxyribonucleic acid; DT, digestive tract; DVT, deep vein thrombosis; ECM, extracellular matrix; ECs, endothelial cells; ETC, electron transport chain; FMO, flavin-containing monooxygenase; GP, glycoprotein; HIF-1, hypoxia-inducible factor-1; Ig, immunoglobulin; IL, interleukin; IS, indoxyl sulfate; LPS, lipopolysaccharide; MAC, membrane attack complex; MRSA, methicillin-resistant <italic>Staphylococcus aureus</italic>; MSI, musculoskeletal infections; MSSA, methicillin-sensitive <italic>Staphylococcus aureus</italic>; NADPH, nicotinamide-adenine dinucleotide phosphate; NETs, neutrophil extracellular traps; NF-κB, nuclear factor kappa B; NGS, next-generation sequencing; NMJ, neuromuscular junction; NOX, NADPH oxidase; PAD4, peptidylarginine deiminase type 4; PE, pulmonary embolism; PKC, protein kinase C; PL, platelets; RBCs, red blood cells; ROS, reactive oxygen species; SCFA, short-chain fatty acids; SIBO, small intestinal bacterial overgrowth; SK, streptokinase; TBARS, thiobarbituric acid reactive substances; TF, tissue factor; TLR-4, toll-like receptor 4; TMA, trimethylamine; TMAO, trimethylamine N-oxide; TNF-α, tumor necrosis factor alfa; t-PA, tissue plasminogen activator; u-PA, urokinase plasminogen activator; VASP, vasodilator-stimulated phosphoprotein; VTE, venous thromboembolism; vWF, von Willebrand factor; WMGS, whole metagenome shotgun.</p>
</sec>
<sec id="s0011" sec-type="COI-statement">
<title>Disclosure</title>
<p>The authors report no conflicts of interest in this work.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="cit0001">
<label>1.</label>
<mixed-citation publication-type="journal"><string-name><surname>Wolberg</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Rosendaal</surname>
<given-names>FR</given-names></string-name>, <string-name><surname>Weitz</surname>
<given-names>JI</given-names></string-name>, et al. <article-title>Venous thrombosis</article-title>. <source/><italic toggle="yes">Nat Rev Dis Primers</italic>. <year>2015</year>;<volume>1</volume>(<issue>1</issue>):<fpage>15006</fpage>. doi:<pub-id pub-id-type="doi">10.1038/nrdp.2015.6</pub-id><pub-id pub-id-type="pmid">27189130</pub-id></mixed-citation>
</ref>
<ref id="cit0002">
<label>2.</label>
<mixed-citation publication-type="journal"><string-name><surname>Suzuki</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Yoshioka</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Ohara</surname>
<given-names>T</given-names></string-name>, et al. <article-title>Risk factors for perioperative venous thromboembolism: a retrospective study in Japanese women with gynecologic diseases</article-title>. <source/><italic toggle="yes">Thromb J</italic>. <year>2010</year>;<volume>8</volume>(<issue>1</issue>):<fpage>17</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1477-9560-8-17</pub-id><pub-id pub-id-type="pmid">21054901</pub-id></mixed-citation>
</ref>
<ref id="cit0003">
<label>3.</label>
<mixed-citation publication-type="journal"><string-name><surname>Liem</surname>
<given-names>TK</given-names></string-name>, <string-name><surname>Huynh</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Moseley</surname>
<given-names>SE</given-names></string-name>, et al. <article-title>Symptomatic perioperative venous thromboembolism is a frequent complication in patients with a history of deep vein thrombosis</article-title>. <source/><italic toggle="yes">J Vasc Surg</italic>. <year>2010</year>;<volume>52</volume>(<issue>3</issue>):<fpage>651</fpage>–<lpage>657</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jvs.2010.04.029</pub-id><pub-id pub-id-type="pmid">20558025</pub-id></mixed-citation>
</ref>
<ref id="cit0004">
<label>4.</label>
<mixed-citation publication-type="journal"><string-name><surname>Mayr</surname>
<given-names>FB</given-names></string-name>, <string-name><surname>Yende</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Angus</surname>
<given-names>DC</given-names></string-name>. <article-title>Epidemiology of severe sepsis</article-title>. <source/><italic toggle="yes">Virulence</italic>. <year>2014</year>;<volume>5</volume>(<issue>1</issue>):<fpage>4</fpage>–<lpage>11</lpage>. doi:<pub-id pub-id-type="doi">10.4161/viru.27372</pub-id><pub-id pub-id-type="pmid">24335434</pub-id></mixed-citation>
</ref>
<ref id="cit0005">
<label>5.</label>
<mixed-citation publication-type="journal"><string-name><surname>Beristain-Covarrubias</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Perez-Toledo</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Thomas</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Henderson</surname>
<given-names>IR</given-names></string-name>, <string-name><surname>Watson</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Cunningham</surname>
<given-names>AF</given-names></string-name>. <article-title>Understanding infection-induced thrombosis: lessons learned from animal models</article-title>. <source/><italic toggle="yes">Front Immunol</italic>. <year>2019</year>;<volume>10</volume>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2019.02569</pub-id></mixed-citation>
</ref>
<ref id="cit0006">
<label>6.</label>
<mixed-citation publication-type="journal"><string-name><surname>Munford</surname>
<given-names>RS</given-names></string-name>. <article-title>Endotoxemia-menace, marker, or mistake?</article-title>
<source/><italic toggle="yes">J Leukoc Biol</italic>. <year>2016</year>;<volume>100</volume>(<issue>4</issue>):<fpage>687</fpage>–<lpage>698</lpage>. doi:<pub-id pub-id-type="doi">10.1189/jlb.3RU0316-151R</pub-id><pub-id pub-id-type="pmid">27418356</pub-id></mixed-citation>
</ref>
<ref id="cit0007">
<label>7.</label>
<mixed-citation publication-type="journal"><string-name><surname>Pretorius</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Mbotwe</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bester</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Robinson</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Kell</surname>
<given-names>DB</given-names></string-name>. <article-title>Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide</article-title>. <source/><italic toggle="yes">J R Soc Interface</italic>. <year>2016</year>;<volume>13</volume>(<issue>122</issue>):<fpage>20160539</fpage>. doi:<pub-id pub-id-type="doi">10.1098/rsif.2016.0539</pub-id><pub-id pub-id-type="pmid">27605168</pub-id></mixed-citation>
</ref>
<ref id="cit0008">
<label>8.</label>
<mixed-citation publication-type="journal"><string-name><surname>Patrakka</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Pienimäki</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Tuomisto</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Oral bacterial signatures in cerebral thrombi of patients with acute ischemic stroke treated with thrombectomy</article-title>. <source/><italic toggle="yes">J Am Heart Assoc</italic>. <year>2019</year>;<volume>8</volume>(<issue>11</issue>). doi:<pub-id pub-id-type="doi">10.1161/JAHA.119.012330</pub-id></mixed-citation>
</ref>
<ref id="cit0009">
<label>9.</label>
<mixed-citation publication-type="journal"><string-name><surname>Hamzeh-Cognasse</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Damien</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Chabert</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pozzetto</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Cognasse</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Garraud</surname>
<given-names>O</given-names></string-name>. <article-title>Platelets and infections - Complex interactions with bacteria</article-title>. <source/><italic toggle="yes">Front Immunol</italic>. <year>2015</year>;<volume>6</volume>:<fpage>1</fpage>–<lpage>18</lpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2015.00082</pub-id><pub-id pub-id-type="pmid">25657648</pub-id></mixed-citation>
</ref>
<ref id="cit0010">
<label>10.</label>
<mixed-citation publication-type="journal"><string-name><surname>Tamowicz</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Mikstacki</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Urbanek</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Zawilska</surname>
<given-names>K</given-names></string-name>. <article-title>Mechanical methods of venous thromboembolism prevention – from the guidelines to the clinical practice</article-title>. <source/><italic toggle="yes">Pol Arch Intern Med</italic>. <year>2019</year>. doi:<pub-id pub-id-type="doi">10.20452/pamw.4482</pub-id></mixed-citation>
</ref>
<ref id="cit0011">
<label>11.</label>
<mixed-citation publication-type="journal"><string-name><surname>Cohen</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Agnelli</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Anderson</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Venous thromboembolism (VTE) in Europe</article-title>. <source/><italic toggle="yes">Thromb Haemost</italic>. <year>2007</year>;<volume>98</volume>(<issue>10</issue>):<fpage>756</fpage>–<lpage>764</lpage>. doi:<pub-id pub-id-type="doi">10.1160/TH07-03-0212</pub-id><pub-id pub-id-type="pmid">17938798</pub-id></mixed-citation>
</ref>
<ref id="cit0012">
<label>12.</label>
<mixed-citation publication-type="journal"><string-name><surname>Adelborg</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Sundbøll</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Sørensen</surname>
<given-names>HT</given-names></string-name>. <article-title>Arterial cardiovascular events and mortality following venous thromboembolism</article-title>. <source/><italic toggle="yes">Ann Transl Med</italic>. <year>2015</year>;<volume>3</volume>(<issue>9</issue>):<fpage>117</fpage>. doi:<pub-id pub-id-type="doi">10.3978/j.issn.2305-5839.2015.04.11</pub-id><pub-id pub-id-type="pmid">26207245</pub-id></mixed-citation>
</ref>
<ref id="cit0013">
<label>13.</label>
<mixed-citation publication-type="journal"><string-name><surname>Mazzolai</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Aboyans</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Ageno</surname>
<given-names>W</given-names></string-name>, et al. <article-title>Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function</article-title>. <source/><italic toggle="yes">Eur Heart J</italic>. <year>2018</year>;<volume>39</volume>(<issue>47</issue>):<fpage>4208</fpage>–<lpage>4218</lpage>. doi:<pub-id pub-id-type="doi">10.1093/eurheartj/ehx003</pub-id><pub-id pub-id-type="pmid">28329262</pub-id></mixed-citation>
</ref>
<ref id="cit0014">
<label>14.</label>
<mixed-citation publication-type="journal"><string-name><surname>Raskob</surname>
<given-names>GE</given-names></string-name>, <string-name><surname>Angchaisuksiri</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Blanco</surname>
<given-names>AN</given-names></string-name>, et al. <article-title>Thrombosis: a major contributor to global disease burden: ISTH steering committee for world thrombosis day the members of the ISTH steering committee for World Thrombosis Day</article-title>. <source/><italic toggle="yes">Thromb Res</italic>. <year>2014</year>;<volume>134</volume>(<issue>5</issue>):<fpage>931</fpage>–<lpage>938</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.thromres.2014.08.014</pub-id><pub-id pub-id-type="pmid">25312343</pub-id></mixed-citation>
</ref>
<ref id="cit0015">
<label>15.</label>
<mixed-citation publication-type="journal"><string-name><surname>Youn</surname>
<given-names>YJ</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>J</given-names></string-name>. <article-title>Chronic venous insufficiency and varicose veins of the lower extremities</article-title>. <source/><italic toggle="yes">Korean J Intern Med</italic>. <year>2019</year>;<volume>34</volume>(<issue>2</issue>):<fpage>269</fpage>–<lpage>283</lpage>. doi:<pub-id pub-id-type="doi">10.3904/kjim.2018.230</pub-id><pub-id pub-id-type="pmid">30360023</pub-id></mixed-citation>
</ref>
<ref id="cit0016">
<label>16.</label>
<mixed-citation publication-type="journal"><string-name><surname>Lejay</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Koncar</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Diener</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Vega de Ceniga</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Chakfé</surname>
<given-names>N</given-names></string-name>. <article-title>Post-operative infection of prosthetic materials or stents involving the supra-aortic trunks: a comprehensive review</article-title>. <source/><italic toggle="yes">Eur J Vasc Endovasc Surg</italic>. <year>2018</year>;<volume>56</volume>(<issue>6</issue>):<fpage>885</fpage>–<lpage>900</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ejvs.2018.07.016</pub-id><pub-id pub-id-type="pmid">30121172</pub-id></mixed-citation>
</ref>
<ref id="cit0017">
<label>17.</label>
<mixed-citation publication-type="journal"><string-name><surname>Branchford</surname>
<given-names>BR</given-names></string-name>, <string-name><surname>Carpenter</surname>
<given-names>SL</given-names></string-name>. <article-title>The role of inflammation in venous thromboembolism</article-title>. <source/><italic toggle="yes">Front Pediatr</italic>. <year>2018</year>;<volume>6</volume>. doi:<pub-id pub-id-type="doi">10.3389/fped.2018.00142</pub-id></mixed-citation>
</ref>
<ref id="cit0018">
<label>18..</label>
<mixed-citation publication-type="journal"><collab>Integrative HM</collab>. <article-title>The integrative human microbiome project: dynamic analysis of microbiome-host omics profiles during periods of human health and disease</article-title>. <source/><italic toggle="yes">Cell Host Microbe</italic>. <year>2014</year>;<volume>16</volume>(<issue>3</issue>):<fpage>276</fpage>–<lpage>289</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chom.2014.08.014</pub-id><pub-id pub-id-type="pmid">25211071</pub-id></mixed-citation>
</ref>
<ref id="cit0019">
<label>19.</label>
<mixed-citation publication-type="journal"><string-name><surname>Sender</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Fuchs</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Milo</surname>
<given-names>R</given-names></string-name>. <article-title>Revised estimates for the number of human and bacteria cells in the body</article-title>. <source/><italic toggle="yes">PLoS Biol</italic>. <year>2016</year>;<volume>14</volume>(<issue>8</issue>):<fpage>e1002533</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pbio.1002533</pub-id><pub-id pub-id-type="pmid">27541692</pub-id></mixed-citation>
</ref>
<ref id="cit0020">
<label>20.</label>
<mixed-citation publication-type="journal"><string-name><surname>Lloyd-Price</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Abu-Ali</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Huttenhower</surname>
<given-names>C</given-names></string-name>. <article-title>The healthy human microbiome</article-title>. <source/><italic toggle="yes">Genome Med</italic>. <year>2016</year>;<volume>8</volume>(<issue>1</issue>):<fpage>51</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13073-016-0307-y</pub-id><pub-id pub-id-type="pmid">27122046</pub-id></mixed-citation>
</ref>
<ref id="cit0021">
<label>21.</label>
<mixed-citation publication-type="journal"><string-name><surname>Petersen</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Round</surname>
<given-names>JL</given-names></string-name>. <article-title>Defining dysbiosis and its influence on host immunity and disease</article-title>. <source/><italic toggle="yes">Cell Microbiol</italic>. <year>2014</year>;<volume>16</volume>(<issue>7</issue>):<fpage>1024</fpage>–<lpage>1033</lpage>. doi:<pub-id pub-id-type="doi">10.1111/cmi.12308</pub-id><pub-id pub-id-type="pmid">24798552</pub-id></mixed-citation>
</ref>
<ref id="cit0022">
<label>22.</label>
<mixed-citation publication-type="journal"><string-name><surname>Ahmad</surname>
<given-names>AF</given-names></string-name>, <string-name><surname>Dwivedi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>O’Gara</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Caparros-Martin</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ward</surname>
<given-names>NC</given-names></string-name>. <article-title>The gut microbiome and cardiovascular disease: current knowledge and clinical potential</article-title>. <source/><italic toggle="yes">Am J Physiol Heart Circ Physiol</italic>. <year>2019</year>;<volume>317</volume>(<issue>5</issue>):<fpage>H923</fpage>–<lpage>H938</lpage>. doi:<pub-id pub-id-type="doi">10.1152/ajpheart.00376.2019</pub-id><pub-id pub-id-type="pmid">31469291</pub-id></mixed-citation>
</ref>
<ref id="cit0023">
<label>23.</label>
<mixed-citation publication-type="journal"><string-name><surname>Krüger</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Vielreicher</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kapitan</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Jacobsen</surname>
<given-names>ID</given-names></string-name>, <string-name><surname>Niemiec</surname>
<given-names>MJ</given-names></string-name>. <article-title>Fungal-bacterial interactions in health and disease</article-title>. <source/><italic toggle="yes">Pathogens</italic>. <year>2019</year>;<volume>8</volume>(<issue>2</issue>):<fpage>70</fpage>. doi:<pub-id pub-id-type="doi">10.3390/pathogens8020070</pub-id></mixed-citation>
</ref>
<ref id="cit0024">
<label>24.</label>
<mixed-citation publication-type="journal"><string-name><surname>Païssé</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Valle</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Servant</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Comprehensive description of blood microbiome from healthy donors assessed by 16S targeted metagenomic sequencing</article-title>. <source/><italic toggle="yes">Transfusion</italic>. <year>2016</year>;<volume>56</volume>(<issue>5</issue>):<fpage>1138</fpage>–<lpage>1147</lpage>. doi:<pub-id pub-id-type="doi">10.1111/trf.13477</pub-id><pub-id pub-id-type="pmid">26865079</pub-id></mixed-citation>
</ref>
<ref id="cit0025">
<label>25.</label>
<mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>X</given-names></string-name>, <string-name><surname>He</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>J</given-names></string-name>. <article-title>Identification and characterization of blood and neutrophil-associated microbiomes in patients with severe acute pancreatitis using next-generation sequencing</article-title>. <source/><italic toggle="yes">Front Cell Infect Microbiol</italic>. <year>2018</year>;<volume>8</volume>. doi:<pub-id pub-id-type="doi">10.3389/fcimb.2018.00005</pub-id></mixed-citation>
</ref>
<ref id="cit0026">
<label>26.</label>
<mixed-citation publication-type="journal"><string-name><surname>Castillo</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Rifkin</surname>
<given-names>RF</given-names></string-name>, <string-name><surname>Cowan</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Potgieter</surname>
<given-names>M</given-names></string-name>. <article-title>The healthy human blood microbiome: fact or fiction?</article-title>
<source/><italic toggle="yes">Front Cell Infect Microbiol</italic>. <year>2019</year>;<volume>9</volume>. doi:<pub-id pub-id-type="doi">10.3389/fcimb.2019.00148</pub-id></mixed-citation>
</ref>
<ref id="cit0027">
<label>27.</label>
<mixed-citation publication-type="journal"><string-name><surname>Qiu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Jing</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Dong</surname>
<given-names>C</given-names></string-name>. <article-title>Association between blood microbiome and type 2 diabetes mellitus: a nested case‐control study</article-title>. <source/><italic toggle="yes">J Clin Lab Anal</italic>. <year>2019</year>;<volume>33</volume>(<issue>4</issue>):<fpage>e22842</fpage>. doi:<pub-id pub-id-type="doi">10.1002/jcla.22842</pub-id><pub-id pub-id-type="pmid">30714640</pub-id></mixed-citation>
</ref>
<ref id="cit0028">
<label>28.</label>
<mixed-citation publication-type="journal"><string-name><surname>Potgieter</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bester</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kell</surname>
<given-names>DB</given-names></string-name>, <string-name><surname>Pretorius</surname>
<given-names>E</given-names></string-name>. <article-title>The dormant blood microbiome in chronic, inflammatory diseases</article-title>. <source/><italic toggle="yes">FEMS Microbiol Rev</italic>. <year>2015</year>;<volume>39</volume>(<issue>4</issue>):<fpage>567</fpage>–<lpage>591</lpage>. doi:<pub-id pub-id-type="doi">10.1093/femsre/fuv013</pub-id><pub-id pub-id-type="pmid">25940667</pub-id></mixed-citation>
</ref>
<ref id="cit0029">
<label>29.</label>
<mixed-citation publication-type="journal"><string-name><surname>Nemati</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Dietz</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Anstadt</surname>
<given-names>EJ</given-names></string-name>, et al. <article-title>Deposition and hydrolysis of serine dipeptide lipids of Bacteroidetes bacteria in human arteries: relationship to atherosclerosis</article-title>. <source/><italic toggle="yes">J Lipid Res</italic>. <year>2017</year>;<volume>58</volume>(<issue>10</issue>):<fpage>1999</fpage>–<lpage>2007</lpage>. doi:<pub-id pub-id-type="doi">10.1194/jlr.m077792</pub-id><pub-id pub-id-type="pmid">28814639</pub-id></mixed-citation>
</ref>
<ref id="cit0030">
<label>30.</label>
<mixed-citation publication-type="journal"><string-name><surname>Rangé</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Labreuche</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Louedec</surname>
<given-names>L</given-names></string-name>, et al. <article-title>Periodontal bacteria in human carotid atherothrombosis as a potential trigger for neutrophil activation</article-title>. <source/><italic toggle="yes">Atherosclerosis</italic>. <year>2014</year>;<volume>236</volume>(<issue>2</issue>):<fpage>448</fpage>–<lpage>455</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2014.07.034</pub-id><pub-id pub-id-type="pmid">25173070</pub-id></mixed-citation>
</ref>
<ref id="cit0031">
<label>31.</label>
<mixed-citation publication-type="journal"><string-name><surname>Kiouptsi</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Jäckel</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pontarollo</surname>
<given-names>G</given-names></string-name>, et al. <article-title>The microbiota promotes arterial thrombosis in low-density lipoprotein receptor-deficient mice</article-title>. <source/><italic toggle="yes">mBio</italic>. <year>2019</year>;<volume>10</volume>(<issue>5</issue>):<fpage>e02298</fpage>–<lpage>19</lpage>. doi:<pub-id pub-id-type="doi">10.1128/mBio.02298-19</pub-id><pub-id pub-id-type="pmid">31641089</pub-id></mixed-citation>
</ref>
<ref id="cit0032">
<label>32.</label>
<mixed-citation publication-type="journal"><string-name><surname>Samarasekara</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Munasinghe</surname>
<given-names>J</given-names></string-name>. <article-title>Dengue shock syndrome complicated with acute liver failure and kidney injury, infective endocarditis, and deep vein thrombosis: a case report</article-title>. <source/><italic toggle="yes">J Med Case Rep</italic>. <year>2018</year>;<volume>12</volume>(<issue>1</issue>):<fpage>321</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13256-018-1862-1</pub-id><pub-id pub-id-type="pmid">30373645</pub-id></mixed-citation>
</ref>
<ref id="cit0033">
<label>33.</label>
<mixed-citation publication-type="journal"><string-name><surname>Dolapsakis</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Kranidioti</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Katsila</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Samarkos</surname>
<given-names>M</given-names></string-name>. <article-title>Cavernous sinus thrombosis due to ipsilateral sphenoid sinusitis</article-title>. <source/><italic toggle="yes">BMJ Case Rep</italic>. <year>2019</year>;<volume>12</volume>(<issue>1</issue>):<fpage>e227302</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bcr-2018-227302</pub-id></mixed-citation>
</ref>
<ref id="cit0034">
<label>34.</label>
<mixed-citation publication-type="journal"><string-name><surname>Periayah</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Halim</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Mat Saad</surname>
<given-names>AZ</given-names></string-name>. <article-title>Mechanism action of platelets and crucial blood coagulation pathways in hemostasis</article-title>. <source/><italic toggle="yes">Int J Hematol Oncol Stem Cell Res</italic>. <year>2017</year>;<volume>11</volume>(<issue>4</issue>):<fpage>319</fpage>–<lpage>327</lpage>.<pub-id pub-id-type="pmid">29340130</pub-id></mixed-citation>
</ref>
<ref id="cit0035">
<label>35.</label>
<mixed-citation publication-type="journal"><string-name><surname>Smith</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Travers</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Morrissey</surname>
<given-names>JH</given-names></string-name>. <article-title>How it all starts: initiation of the clotting cascade</article-title>. <source/><italic toggle="yes">Crit Rev Biochem Mol Biol</italic>. <year>2015</year>;<volume>50</volume>(<issue>4</issue>):<fpage>326</fpage>–<lpage>336</lpage>. doi:<pub-id pub-id-type="doi">10.3109/10409238.2015.1050550</pub-id><pub-id pub-id-type="pmid">26018600</pub-id></mixed-citation>
</ref>
<ref id="cit0036">
<label>36.</label>
<mixed-citation publication-type="journal"><string-name><surname>Berends</surname>
<given-names>ETM</given-names></string-name>, <string-name><surname>Kuipers</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ravesloot</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Urbanus</surname>
<given-names>RT</given-names></string-name>, <string-name><surname>Rooijakkers</surname>
<given-names>SHM</given-names></string-name>. <article-title>Bacteria under stress by complement and coagulation</article-title>. <source/><italic toggle="yes">FEMS Microbiol Rev</italic>. <year>2014</year>;<volume>38</volume>(<issue>6</issue>):<fpage>1146</fpage>–<lpage>1171</lpage>. doi:<pub-id pub-id-type="doi">10.1111/1574-6976.12080</pub-id><pub-id pub-id-type="pmid">25065463</pub-id></mixed-citation>
</ref>
<ref id="cit0037">
<label>37.</label>
<mixed-citation publication-type="journal"><string-name><surname>Frick</surname>
<given-names>I-M</given-names></string-name>, <string-name><surname>Björck</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Herwald</surname>
<given-names>H</given-names></string-name>. <article-title>The dual role of the contact system in bacterial infectious disease</article-title>. <source/><italic toggle="yes">Thromb Haemost</italic>. <year>2007</year>;<volume>98</volume>(<issue>09</issue>):<fpage>497</fpage>–<lpage>502</lpage>. doi:<pub-id pub-id-type="doi">10.1160/TH07-01-0051</pub-id><pub-id pub-id-type="pmid">17849037</pub-id></mixed-citation>
</ref>
<ref id="cit0038">
<label>38.</label>
<mixed-citation publication-type="journal"><string-name><surname>Nickel</surname>
<given-names>KF</given-names></string-name>, <string-name><surname>Renné</surname>
<given-names>T</given-names></string-name>. <article-title>Crosstalk of the plasma contact system with bacteria</article-title>. <source/><italic toggle="yes">Thromb Res</italic>. <year>2012</year>;<volume>130</volume>:<fpage>S78</fpage>–<lpage>S83</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.thromres.2012.08.284</pub-id><pub-id pub-id-type="pmid">23026673</pub-id></mixed-citation>
</ref>
<ref id="cit0039">
<label>39.</label>
<mixed-citation publication-type="journal"><string-name><surname>Antoniak</surname>
<given-names>S</given-names></string-name>. <article-title>The coagulation system in host defense</article-title>. <source/><italic toggle="yes">Res Pract Thromb Haemost</italic>. <year>2018</year>;<volume>2</volume>(<issue>3</issue>):<fpage>549</fpage>–<lpage>557</lpage>. doi:<pub-id pub-id-type="doi">10.1002/rth2.12109</pub-id><pub-id pub-id-type="pmid">30046760</pub-id></mixed-citation>
</ref>
<ref id="cit0040">
<label>40.</label>
<mixed-citation publication-type="journal"><string-name><surname>Bhattacharya</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ploplis</surname>
<given-names>VA</given-names></string-name>, <string-name><surname>Castellino</surname>
<given-names>FJ</given-names></string-name>. <article-title>Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination</article-title>. <source/><italic toggle="yes">J Biomed Biotechnol</italic>. <year>2012</year>;<volume>2012</volume>:<fpage>1</fpage>–<lpage>19</lpage>. doi:<pub-id pub-id-type="doi">10.1155/2012/482096</pub-id><pub-id pub-id-type="pmid">21836813</pub-id></mixed-citation>
</ref>
<ref id="cit0041">
<label>41.</label>
<mixed-citation publication-type="journal"><string-name><surname>Adivitiya</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Khasa</surname>
<given-names>YP</given-names></string-name>. <article-title>The evolution of recombinant thrombolytics: current status and future directions</article-title>. <source/><italic toggle="yes">Bioengineered</italic>. <year>2017</year>;<volume>8</volume>(<issue>4</issue>):<fpage>331</fpage>–<lpage>358</lpage>. doi:<pub-id pub-id-type="doi">10.1080/21655979.2016.1229718</pub-id><pub-id pub-id-type="pmid">27696935</pub-id></mixed-citation>
</ref>
<ref id="cit0042">
<label>42.</label>
<mixed-citation publication-type="journal"><string-name><surname>Delano</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Ward</surname>
<given-names>PA</given-names></string-name>. <article-title>The immune system’s role in sepsis progression, resolution, and long-term outcome</article-title>. <source/><italic toggle="yes">Immunol Rev</italic>. <year>2016</year>;<volume>274</volume>(<issue>1</issue>):<fpage>330</fpage>–<lpage>353</lpage>. doi:<pub-id pub-id-type="doi">10.1111/imr.12499</pub-id><pub-id pub-id-type="pmid">27782333</pub-id></mixed-citation>
</ref>
<ref id="cit0043">
<label>43.</label>
<mixed-citation publication-type="journal"><string-name><surname>Peetermans</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Vanassche</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Liesenborghs</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Lijnen</surname>
<given-names>RH</given-names></string-name>, <string-name><surname>Verhamme</surname>
<given-names>P</given-names></string-name>. <article-title>Bacterial pathogens activate plasminogen to breach tissue barriers and escape from innate immunity</article-title>. <source/><italic toggle="yes">Crit Rev Microbiol</italic>. <year>2016</year>;<volume>42</volume>(<issue>6</issue>):<fpage>866</fpage>–<lpage>882</lpage>. doi:<pub-id pub-id-type="doi">10.3109/1040841X.2015.1080214</pub-id><pub-id pub-id-type="pmid">26485450</pub-id></mixed-citation>
</ref>
<ref id="cit0044">
<label>44.</label>
<mixed-citation publication-type="journal"><string-name><surname>Rittirsch</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Flierl</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Ward</surname>
<given-names>PA</given-names></string-name>. <article-title>Harmful molecular mechanisms in sepsis</article-title>. <source/><italic toggle="yes">Nat Rev Immunol</italic>. <year>2008</year>;<volume>8</volume>(<issue>10</issue>):<fpage>776</fpage>–<lpage>787</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nri2402</pub-id><pub-id pub-id-type="pmid">18802444</pub-id></mixed-citation>
</ref>
<ref id="cit0045">
<label>45.</label>
<mixed-citation publication-type="journal"><string-name><surname>Duran-Bedolla</surname>
<given-names>J</given-names></string-name>, <string-name><surname>de Oca-sandoval</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Saldaña-Navor</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Villalobos-Silva</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Rodriguez</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Rivas-Arancibia</surname>
<given-names>S</given-names></string-name>. <article-title>Sepsis, mitochondrial failure and multiple organ dysfunction</article-title>. <source/><italic toggle="yes">Clin Invest Med</italic>. <year>2014</year>;<volume>37</volume>(<issue>2</issue>):<fpage>58</fpage>. doi:<pub-id pub-id-type="doi">10.25011/cim.v37i2.21087</pub-id></mixed-citation>
</ref>
<ref id="cit0046">
<label>46.</label>
<mixed-citation publication-type="journal"><string-name><surname>Paiva</surname>
<given-names>CN</given-names></string-name>, <string-name><surname>Bozza</surname>
<given-names>MT</given-names></string-name>. <article-title>Are reactive oxygen species always detrimental to pathogens?</article-title>
<source/><italic toggle="yes">Antioxid Redox Signal</italic>. <year>2014</year>;<volume>20</volume>(<issue>6</issue>):<fpage>1000</fpage>–<lpage>1037</lpage>. doi:<pub-id pub-id-type="doi">10.1089/ars.2013.5447</pub-id><pub-id pub-id-type="pmid">23992156</pub-id></mixed-citation>
</ref>
<ref id="cit0047">
<label>47.</label>
<mixed-citation publication-type="journal"><string-name><surname>Alberdi</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Cabezas-Cruz</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Prados</surname>
<given-names>PE</given-names></string-name>, <string-name><surname>Rayo</surname>
<given-names>MV</given-names></string-name>, <string-name><surname>Artigas-Jerónimo</surname>
<given-names>S</given-names></string-name>, <string-name><surname>de la Fuente</surname>
<given-names>J</given-names></string-name>. <article-title>The redox metabolic pathways function to limit Anaplasma phagocytophilum infection and multiplication while preserving fitness in tick vector cells</article-title>. <source/><italic toggle="yes">Sci Rep</italic>. <year>2019</year>;<volume>9</volume>(<issue>1</issue>):<fpage>13236</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-019-49766-x</pub-id><pub-id pub-id-type="pmid">31520000</pub-id></mixed-citation>
</ref>
<ref id="cit0048">
<label>48.</label>
<mixed-citation publication-type="journal"><string-name><surname>Ivanov</surname>
<given-names>AV</given-names></string-name>, <string-name><surname>Bartosch</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Isaguliants</surname>
<given-names>MG</given-names></string-name>. <article-title>Oxidative stress in infection and consequent disease</article-title>. <source/><italic toggle="yes">Oxid Med Cell Longev</italic>. <year>2017</year>;<volume>2017</volume>:<fpage>1</fpage>–<lpage>3</lpage>. doi:<pub-id pub-id-type="doi">10.1155/2017/3496043</pub-id></mixed-citation>
</ref>
<ref id="cit0049">
<label>49.</label>
<mixed-citation publication-type="journal"><string-name><surname>Ray</surname>
<given-names>PD</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>B-W</given-names></string-name>, <string-name><surname>Tsuji</surname>
<given-names>Y</given-names></string-name>. <article-title>Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling</article-title>. <source/><italic toggle="yes">Cell Signal</italic>. <year>2012</year>;<volume>24</volume>(<issue>5</issue>):<fpage>981</fpage>–<lpage>990</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cellsig.2012.01.008</pub-id><pub-id pub-id-type="pmid">22286106</pub-id></mixed-citation>
</ref>
<ref id="cit0050">
<label>50.</label>
<mixed-citation publication-type="journal"><string-name><surname>Qiao</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Arthur</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Gardiner</surname>
<given-names>EE</given-names></string-name>, <string-name><surname>Andrews</surname>
<given-names>RK</given-names></string-name>, <string-name><surname>Zeng</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>K</given-names></string-name>. <article-title>Regulation of platelet activation and thrombus formation by reactive oxygen species</article-title>. <source/><italic toggle="yes">Redox Biol</italic>. <year>2018</year>;<volume>14</volume>:<fpage>126</fpage>–<lpage>130</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.redox.2017.08.021</pub-id><pub-id pub-id-type="pmid">28888895</pub-id></mixed-citation>
</ref>
<ref id="cit0051">
<label>51.</label>
<mixed-citation publication-type="journal"><string-name><surname>Violi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Pignatelli</surname>
<given-names>P</given-names></string-name>. <article-title>Platelet oxidative stress and thrombosis</article-title>. <source/><italic toggle="yes">Thromb Res</italic>. <year>2012</year>;<volume>129</volume>(<issue>3</issue>):<fpage>378</fpage>–<lpage>381</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.thromres.2011.12.002</pub-id><pub-id pub-id-type="pmid">22209450</pub-id></mixed-citation>
</ref>
<ref id="cit0052">
<label>52.</label>
<mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Yao</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>S</given-names></string-name>. <article-title>The role of oxidative stress in decreased acetylcholinesterase activity at the neuromuscular junction of the diaphragm during sepsis</article-title>. <source/><italic toggle="yes">Oxid Med Cell Longev</italic>. <year>2017</year>;<volume>2017</volume>:<fpage>1</fpage>–<lpage>6</lpage>. doi:<pub-id pub-id-type="doi">10.1155/2017/9718615</pub-id></mixed-citation>
</ref>
<ref id="cit0053">
<label>53.</label>
<mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>Q-S</given-names></string-name>, <string-name><surname>Zheng</surname>
<given-names>Y-M</given-names></string-name>, <string-name><surname>Dong</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Ho</surname>
<given-names>Y-S</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Y-X</given-names></string-name>. <article-title>Role of mitochondrial reactive oxygen species in hypoxia-dependent increase in intracellular calcium in pulmonary artery myocytes</article-title>. <source/><italic toggle="yes">Free Radic Biol Med</italic>. <year>2007</year>;<volume>42</volume>(<issue>5</issue>):<fpage>642</fpage>–<lpage>653</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2006.12.008</pub-id><pub-id pub-id-type="pmid">17291988</pub-id></mixed-citation>
</ref>
<ref id="cit0054">
<label>54.</label>
<mixed-citation publication-type="journal"><string-name><surname>Tafani</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sansone</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Limana</surname>
<given-names>F</given-names></string-name>, et al. <article-title>The interplay of reactive oxygen species, hypoxia, inflammation, and sirtuins in cancer initiation and progression</article-title>. <source/><italic toggle="yes">Oxid Med Cell Longev</italic>. <year>2016</year>;<volume>2016</volume>:<fpage>1</fpage>–<lpage>18</lpage>. doi:<pub-id pub-id-type="doi">10.1155/2016/3907147</pub-id></mixed-citation>
</ref>
<ref id="cit0055">
<label>55.</label>
<mixed-citation publication-type="journal"><string-name><surname>Yang</surname>
<given-names>S-L</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Xiong</surname>
<given-names>Z-F</given-names></string-name>, <string-name><surname>Fang</surname>
<given-names>X</given-names></string-name>. <article-title>Progress on hypoxia-inducible factor-3: its structure, gene regulation and biological function (Review)</article-title>. <source/><italic toggle="yes">Mol Med Rep</italic>. <year>2015</year>;<volume>12</volume>(<issue>2</issue>):<fpage>2411</fpage>–<lpage>2416</lpage>. doi:<pub-id pub-id-type="doi">10.3892/mmr.2015.3689</pub-id><pub-id pub-id-type="pmid">25936862</pub-id></mixed-citation>
</ref>
<ref id="cit0056">
<label>56.</label>
<mixed-citation publication-type="journal"><string-name><surname>Ziello</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Jovin</surname>
<given-names>IS</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>Y</given-names></string-name>. <article-title>Hypoxia-inducible factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia</article-title>. <source/><italic toggle="yes">Yale J Biol Med</italic>. <year>2007</year>;<volume>80</volume>(<issue>2</issue>):<fpage>51</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="pmid">18160990</pub-id></mixed-citation>
</ref>
<ref id="cit0057">
<label>57.</label>
<mixed-citation publication-type="journal"><string-name><surname>Weidemann</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>RS</given-names></string-name>. <article-title>Biology of HIF-1α</article-title>. <source/><italic toggle="yes">Cell Death Differ</italic>. <year>2008</year>;<volume>15</volume>(<issue>4</issue>):<fpage>621</fpage>–<lpage>627</lpage>. doi:<pub-id pub-id-type="doi">10.1038/cdd.2008.12</pub-id><pub-id pub-id-type="pmid">18259201</pub-id></mixed-citation>
</ref>
<ref id="cit0058">
<label>58.</label>
<mixed-citation publication-type="journal"><string-name><surname>Malone</surname>
<given-names>PC</given-names></string-name>. <article-title>The aetiology of deep venous thrombosis</article-title>. <source/><italic toggle="yes">QJM</italic>. <year>2006</year>;<volume>99</volume>(<issue>9</issue>):<fpage>581</fpage>–<lpage>593</lpage>. doi:<pub-id pub-id-type="doi">10.1093/qjmed/hcl070</pub-id><pub-id pub-id-type="pmid">16905749</pub-id></mixed-citation>
</ref>
<ref id="cit0059">
<label>59.</label>
<mixed-citation publication-type="journal"><string-name><surname>Prchal</surname>
<given-names>JT</given-names></string-name>. <article-title>Hypoxia and thrombosis</article-title>. <source/><italic toggle="yes">Blood</italic>. <year>2018</year>;<volume>132</volume>(<issue>4</issue>):<fpage>348</fpage>–<lpage>349</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood-2018-06-854976</pub-id><pub-id pub-id-type="pmid">30049732</pub-id></mixed-citation>
</ref>
<ref id="cit0060">
<label>60.</label>
<mixed-citation publication-type="journal"><string-name><surname>Kempf</surname>
<given-names>VAJ</given-names></string-name>, <string-name><surname>Lebiedziejewski</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Alitalo</surname>
<given-names>K</given-names></string-name>, et al. <article-title>Activation of hypoxia-inducible factor-1 in bacillary angiomatosis</article-title>. <source/><italic toggle="yes">Circulation</italic>. <year>2005</year>;<volume>111</volume>(<issue>8</issue>):<fpage>1054</fpage>–<lpage>1062</lpage>. doi:<pub-id pub-id-type="doi">10.1161/01.CIR.0000155608.07691.B7</pub-id><pub-id pub-id-type="pmid">15723970</pub-id></mixed-citation>
</ref>
<ref id="cit0061">
<label>61.</label>
<mixed-citation publication-type="journal"><string-name><surname>Yeung</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Holinstat</surname>
<given-names>M</given-names></string-name>. <article-title>Platelet signaling and disease: targeted therapy for thrombosis and other related diseases</article-title>. <source/><italic toggle="yes">Pharmacol Rev</italic>. <year>2018</year>;<volume>70</volume>(<issue>3</issue>):<fpage>526</fpage>–<lpage>548</lpage>. doi:<pub-id pub-id-type="doi">10.1124/pr.117.014530</pub-id><pub-id pub-id-type="pmid">29925522</pub-id></mixed-citation>
</ref>
<ref id="cit0062">
<label>62.</label>
<mixed-citation publication-type="journal"><string-name><surname>Korzonek-Szlacheta</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Zubelewicz-Szkodzińska</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Gąsior</surname>
<given-names>M</given-names></string-name>. <article-title>Płytki krwi — ogniwo łączące zakrzepicę ze stanem zapalnym</article-title>. <source/><italic toggle="yes">Folia Cardiol</italic>. <year>2018</year>;<volume>13</volume>(<issue>4</issue>):<fpage>303</fpage>–<lpage>308</lpage>. doi:<pub-id pub-id-type="doi">10.5603/FC.2018.0068</pub-id></mixed-citation>
</ref>
<ref id="cit0063">
<label>63.</label>
<mixed-citation publication-type="book"><string-name><surname>Xu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>An</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Yin</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>X</given-names></string-name>. <chapter-title>Platelet and immunity in transfusion medicine</chapter-title> In: <source/><italic toggle="yes">Transfusion Medicine and Scientific Developments</italic>. <publisher-name>InTech</publisher-name>; <year>2017</year>:<fpage>55</fpage>. doi:<pub-id pub-id-type="doi">10.5772/intechopen.69135</pub-id></mixed-citation>
</ref>
<ref id="cit0064">
<label>64.</label>
<mixed-citation publication-type="book"><string-name><surname>Kerrigan</surname>
<given-names>SW</given-names></string-name>. <chapter-title>Platelet interactions with bacteria</chapter-title> in: <source/><italic toggle="yes">the non-thrombotic role of platelets in health and Disease</italic>. <publisher-name>InTech</publisher-name>; <year>2015</year>:<fpage>65</fpage>. doi<pub-id pub-id-type="doi">10.5772/60531</pub-id></mixed-citation>
</ref>
<ref id="cit0065">
<label>65.</label>
<mixed-citation publication-type="journal"><string-name><surname>Kerrigan</surname>
<given-names>SW</given-names></string-name>, <string-name><surname>Cox</surname>
<given-names>D</given-names></string-name>. <article-title>Platelet–bacterial interactions</article-title>. <source/><italic toggle="yes">Cell Mol Life Sci</italic>. <year>2010</year>;<volume>67</volume>(<issue>4</issue>):<fpage>513</fpage>–<lpage>523</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00018-009-0207-z</pub-id><pub-id pub-id-type="pmid">20091082</pub-id></mixed-citation>
</ref>
<ref id="cit0066">
<label>66.</label>
<mixed-citation publication-type="journal"><string-name><surname>Kerrigan</surname>
<given-names>SW</given-names></string-name>, <string-name><surname>Douglas</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Wray</surname>
<given-names>A</given-names></string-name>, et al. <article-title>A role for glycoprotein Ib in Streptococcus sanguis–induced platelet aggregation</article-title>. <source/><italic toggle="yes">Blood</italic>. <year>2002</year>;<volume>100</volume>(<issue>2</issue>):<fpage>509</fpage>–<lpage>516</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood.V100.2.509</pub-id><pub-id pub-id-type="pmid">12091342</pub-id></mixed-citation>
</ref>
<ref id="cit0067">
<label>67.</label>
<mixed-citation publication-type="journal"><string-name><surname>Byrne</surname>
<given-names>MF</given-names></string-name>, <string-name><surname>Kerrigan</surname>
<given-names>SW</given-names></string-name>, <string-name><surname>Corcoran</surname>
<given-names>PA</given-names></string-name>, et al. <article-title>Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation</article-title>. <source/><italic toggle="yes">Gastroenterology</italic>. <year>2003</year>;<volume>124</volume>(<issue>7</issue>):<fpage>1846</fpage>–<lpage>1854</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0016-5085(03)00397-4</pub-id><pub-id pub-id-type="pmid">12806618</pub-id></mixed-citation>
</ref>
<ref id="cit0068">
<label>68.</label>
<mixed-citation publication-type="journal"><string-name><surname>McAdow</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Missiakas</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Schneewind</surname>
<given-names>O</given-names></string-name>. <article-title>Staphylococcus aureus secretes coagulase and von willebrand factor binding protein to modify the coagulation cascade and establish host infections</article-title>. <source/><italic toggle="yes">J Innate Immun</italic>. <year>2012</year>;<volume>4</volume>(<issue>2</issue>):<fpage>141</fpage>–<lpage>148</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000333447</pub-id><pub-id pub-id-type="pmid">22222316</pub-id></mixed-citation>
</ref>
<ref id="cit0069">
<label>69.</label>
<mixed-citation publication-type="book"><string-name><surname>Crosby</surname>
<given-names>HA</given-names></string-name>, <string-name><surname>Kwiecinski</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Horswill</surname>
<given-names>AR</given-names></string-name>. <chapter-title>Staphylococcus aureus aggregation and coagulation mechanisms, and their function in host–pathogen interactions</chapter-title> In: <source/><italic toggle="yes">Advances in Applied Microbiology</italic>; <year>2016</year>:<fpage>1</fpage>–<lpage>41</lpage>. doi:<pub-id pub-id-type="doi">10.1016/bs.aambs.2016.07.018</pub-id></mixed-citation>
</ref>
<ref id="cit0070">
<label>70.</label>
<mixed-citation publication-type="journal"><string-name><surname>Thomer</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Schneewind</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Missiakas</surname>
<given-names>D</given-names></string-name>. <article-title>Pathogenesis of Staphylococcus aureus bloodstream infections</article-title>. <source/><italic toggle="yes">Annu Rev Pathol</italic>. <year>2016</year>;<volume>11</volume>(<issue>1</issue>):<fpage>343</fpage>–<lpage>364</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev-pathol-012615-044351</pub-id><pub-id pub-id-type="pmid">26925499</pub-id></mixed-citation>
</ref>
<ref id="cit0071">
<label>71.</label>
<mixed-citation publication-type="journal"><string-name><surname>Gros</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ollivier</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Ho-Tin-NoÃ©</surname>
<given-names>B</given-names></string-name>. <article-title>Platelets in inflammation: regulation of leukocyte activities and vascular repair</article-title>. <source/><italic toggle="yes">Front Immunol</italic>. <year>2015</year>;<volume>5</volume>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2014.00678</pub-id></mixed-citation>
</ref>
<ref id="cit0072">
<label>72.</label>
<mixed-citation publication-type="journal"><string-name><surname>Rose</surname>
<given-names>PE</given-names></string-name>, <string-name><surname>Armour</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Williams</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Hill</surname>
<given-names>FG</given-names></string-name>. <article-title>Verotoxin and neuraminidase induced platelet aggregating activity in plasma: their possible role in the pathogenesis of the haemolytic uraemic syndrome</article-title>. <source/><italic toggle="yes">J Clin Pathol</italic>. <year>1985</year>;<volume>38</volume>(<issue>4</issue>):<fpage>438</fpage>–<lpage>441</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jcp.38.4.438</pub-id><pub-id pub-id-type="pmid">2859303</pub-id></mixed-citation>
</ref>
<ref id="cit0073">
<label>73.</label>
<mixed-citation publication-type="journal"><string-name><surname>Guessous</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Marcinkiewicz</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Polanowska-Grabowska</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function</article-title>. <source/><italic toggle="yes">Infect Immun</italic>. <year>2005</year>;<volume>73</volume>(<issue>12</issue>):<fpage>8306</fpage>–<lpage>8316</lpage>. doi:<pub-id pub-id-type="doi">10.1128/IAI.73.12.8306-8316.2005</pub-id><pub-id pub-id-type="pmid">16299328</pub-id></mixed-citation>
</ref>
<ref id="cit0074">
<label>74.</label>
<mixed-citation publication-type="journal"><string-name><surname>Surewaard</surname>
<given-names>BGJ</given-names></string-name>, <string-name><surname>Thanabalasuriar</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Zeng</surname>
<given-names>Z</given-names></string-name>, et al. <article-title>α-Toxin induces platelet aggregation and liver injury during Staphylococcus aureus sepsis</article-title>. <source/><italic toggle="yes">Cell Host Microbe</italic>. <year>2018</year>;<volume>24</volume>(<issue>2</issue>):<fpage>271</fpage>–<lpage>284.e3</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chom.2018.06.017</pub-id><pub-id pub-id-type="pmid">30033122</pub-id></mixed-citation>
</ref>
<ref id="cit0075">
<label>75.</label>
<mixed-citation publication-type="journal"><string-name><surname>Martinod</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Wagner</surname>
<given-names>DD</given-names></string-name>. <article-title>Thrombosis: tangled up in NETs</article-title>. <source/><italic toggle="yes">Blood</italic>. <year>2014</year>;<volume>123</volume>(<issue>18</issue>):<fpage>2768</fpage>–<lpage>2776</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood-2013-10-463646</pub-id><pub-id pub-id-type="pmid">24366358</pub-id></mixed-citation>
</ref>
<ref id="cit0076">
<label>76.</label>
<mixed-citation publication-type="journal"><string-name><surname>Konig</surname>
<given-names>MF</given-names></string-name>, <string-name><surname>Andrade</surname>
<given-names>F</given-names></string-name>. <article-title>A critical reappraisal of neutrophil extracellular traps and NETosis mimics based on differential requirements for protein citrullination</article-title>. <source/><italic toggle="yes">Front Immunol</italic>. <year>2016</year>;<volume>7</volume>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2016.00461</pub-id></mixed-citation>
</ref>
<ref id="cit0077">
<label>77.</label>
<mixed-citation publication-type="journal"><string-name><surname>Lazzaretto</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Fadeel</surname>
<given-names>B</given-names></string-name>. <article-title>Intra- and extracellular degradation of neutrophil extracellular traps by macrophages and dendritic cells</article-title>. <source/><italic toggle="yes">J Immunol</italic>. <year>2019</year>;<volume>203</volume>(<issue>8</issue>):<fpage>2276</fpage>–<lpage>2290</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.1800159</pub-id><pub-id pub-id-type="pmid">31519860</pub-id></mixed-citation>
</ref>
<ref id="cit0078">
<label>78.</label>
<mixed-citation publication-type="journal"><string-name><surname>Scheithauer</surname>
<given-names>TPM</given-names></string-name>, <string-name><surname>Dallinga-Thie</surname>
<given-names>GM</given-names></string-name>, <string-name><surname>de Vos</surname>
<given-names>WM</given-names></string-name>, <string-name><surname>Nieuwdorp</surname>
<given-names>M</given-names></string-name>, <string-name><surname>van Raalte</surname>
<given-names>DH</given-names></string-name>. <article-title>Causality of small and large intestinal microbiota in weight regulation and insulin resistance</article-title>. <source/><italic toggle="yes">Mol Metab</italic>. <year>2016</year>;<volume>5</volume>(<issue>9</issue>):<fpage>759</fpage>–<lpage>770</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molmet.2016.06.002</pub-id><pub-id pub-id-type="pmid">27617199</pub-id></mixed-citation>
</ref>
<ref id="cit0079">
<label>79.</label>
<mixed-citation publication-type="journal"><string-name><surname>Mondot</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Lepage</surname>
<given-names>P</given-names></string-name>. <article-title>The human gut microbiome and its dysfunctions through the meta-omics prism</article-title>. <source/><italic toggle="yes">Ann N Y Acad Sci</italic>. <year>2016</year>;<volume>1372</volume>(<issue>1</issue>):<fpage>9</fpage>–<lpage>19</lpage>. doi:<pub-id pub-id-type="doi">10.1111/nyas.13033</pub-id><pub-id pub-id-type="pmid">26945826</pub-id></mixed-citation>
</ref>
<ref id="cit0080">
<label>80.</label>
<mixed-citation publication-type="journal"><string-name><surname>Vinchi</surname>
<given-names>F</given-names></string-name>. <article-title>Thrombosis prevention</article-title>. <source/><italic toggle="yes">Hemasphere</italic>. <year>2019</year>;<volume>3</volume>(<issue>1</issue>):<fpage>e165</fpage>. doi:<pub-id pub-id-type="doi">10.1097/HS9.0000000000000165</pub-id><pub-id pub-id-type="pmid">31723804</pub-id></mixed-citation>
</ref>
<ref id="cit0081">
<label>81.</label>
<mixed-citation publication-type="journal"><string-name><surname>Shivaji</surname>
<given-names>S</given-names></string-name>. <article-title>We are not alone: a case for the human microbiome in extra intestinal diseases</article-title>. <source/><italic toggle="yes">Gut Pathog</italic>. <year>2017</year>;<volume>9</volume>(<issue>1</issue>):<fpage>13</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13099-017-0163-3</pub-id><pub-id pub-id-type="pmid">28286571</pub-id></mixed-citation>
</ref>
<ref id="cit0082">
<label>82.</label>
<mixed-citation publication-type="journal"><string-name><surname>Khan</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Shrivastava</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Khurshid</surname>
<given-names>M</given-names></string-name>. <article-title>Normal to cancer microbiome transformation and its implication in cancer diagnosis</article-title>. <source/><italic toggle="yes">Biochim Biophys Acta Rev Cancer</italic>. <year>2012</year>;<volume>1826</volume>(<issue>2</issue>):<fpage>331</fpage>–<lpage>337</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbcan.2012.05.005</pub-id></mixed-citation>
</ref>
<ref id="cit0083">
<label>83.</label>
<mixed-citation publication-type="journal"><string-name><surname>Vuong</surname>
<given-names>HE</given-names></string-name>, <string-name><surname>Hsiao</surname>
<given-names>EY</given-names></string-name>. <article-title>Emerging roles for the gut microbiome in autism spectrum disorder</article-title>. <source/><italic toggle="yes">Biol Psychiatry</italic>. <year>2017</year>;<volume>81</volume>(<issue>5</issue>):<fpage>411</fpage>–<lpage>423</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biopsych.2016.08.024</pub-id><pub-id pub-id-type="pmid">27773355</pub-id></mixed-citation>
</ref>
<ref id="cit0084">
<label>84.</label>
<mixed-citation publication-type="journal"><string-name><surname>Singer</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Deutschman</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Seymour</surname>
<given-names>CW</given-names></string-name>, et al. <article-title>The third international consensus definitions for sepsis and septic shock (Sepsis-3)</article-title>. <source/><italic toggle="yes">JAMA</italic>. <year>2016</year>;<volume>315</volume>(<issue>8</issue>):<fpage>801</fpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2016.0287</pub-id><pub-id pub-id-type="pmid">26903338</pub-id></mixed-citation>
</ref>
<ref id="cit0085">
<label>85.</label>
<mixed-citation publication-type="journal"><string-name><surname>Cheng</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>NC</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>HL</given-names></string-name>, <string-name><surname>Lian</surname>
<given-names>YJ</given-names></string-name>. <article-title>Association between small-intestinal bacterial overgrowth and deep vein thrombosis in patients with spinal cord injuries</article-title>. <source/><italic toggle="yes">J Thromb Haemost</italic>. <year>2017</year>;<volume>15</volume>(<issue>2</issue>):<fpage>304</fpage>–<lpage>311</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jth.13583</pub-id><pub-id pub-id-type="pmid">27930853</pub-id></mixed-citation>
</ref>
<ref id="cit0086">
<label>86.</label>
<mixed-citation publication-type="journal"><string-name><surname>Wigg</surname>
<given-names>AJ</given-names></string-name>. <article-title>The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis</article-title>. <source/><italic toggle="yes">Gut</italic>. <year>2001</year>;<volume>48</volume>(<issue>2</issue>):<fpage>206</fpage>–<lpage>211</lpage>. doi:<pub-id pub-id-type="doi">10.1136/gut.48.2.206</pub-id><pub-id pub-id-type="pmid">11156641</pub-id></mixed-citation>
</ref>
<ref id="cit0087">
<label>87.</label>
<mixed-citation publication-type="journal"><string-name><surname>Shanab</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Scully</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Crosbie</surname>
<given-names>O</given-names></string-name>, et al. <article-title>Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8</article-title>. <source/><italic toggle="yes">Dig Dis Sci</italic>. <year>2011</year>;<volume>56</volume>(<issue>5</issue>):<fpage>1524</fpage>–<lpage>1534</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10620-010-1447-3</pub-id><pub-id pub-id-type="pmid">21046243</pub-id></mixed-citation>
</ref>
<ref id="cit0088">
<label>88.</label>
<mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>Y</given-names></string-name>. <article-title>Gut microbiota derived metabolites in cardiovascular health and disease</article-title>. <source/><italic toggle="yes">Protein Cell</italic>. <year>2018</year>;<volume>9</volume>(<issue>5</issue>):<fpage>416</fpage>–<lpage>431</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s13238-018-0549-0</pub-id><pub-id pub-id-type="pmid">29725935</pub-id></mixed-citation>
</ref>
<ref id="cit0089">
<label>89.</label>
<mixed-citation publication-type="journal"><string-name><surname>Yang</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Du</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>X</given-names></string-name>, et al. <article-title>Indoxyl sulfate induces platelet hyperactivity and contributes to chronic kidney disease–associated thrombosis in mice</article-title>. <source/><italic toggle="yes">Blood</italic>. <year>2017</year>;<volume>129</volume>(<issue>19</issue>):<fpage>2667</fpage>–<lpage>2679</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood-2016-10-744060</pub-id><pub-id pub-id-type="pmid">28264799</pub-id></mixed-citation>
</ref>
<ref id="cit0090">
<label>90.</label>
<mixed-citation publication-type="journal"><string-name><surname>Brown</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Hazen</surname>
<given-names>SL</given-names></string-name>. <article-title>Microbial modulation of cardiovascular disease</article-title>. <source/><italic toggle="yes">Nat Rev Microbiol</italic>. <year>2018</year>;<volume>16</volume>(<issue>3</issue>):<fpage>171</fpage>–<lpage>181</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrmicro.2017.149</pub-id><pub-id pub-id-type="pmid">29307889</pub-id></mixed-citation>
</ref>
<ref id="cit0091">
<label>91.</label>
<mixed-citation publication-type="journal"><string-name><surname>Yancey</surname>
<given-names>PH</given-names></string-name>. <article-title>Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses</article-title>. <source/><italic toggle="yes">J Exp Biol</italic>. <year>2005</year>;<volume>208</volume>(<issue>15</issue>):<fpage>2819</fpage>–<lpage>2830</lpage>. doi:<pub-id pub-id-type="doi">10.1242/jeb.01730</pub-id><pub-id pub-id-type="pmid">16043587</pub-id></mixed-citation>
</ref>
<ref id="cit0092">
<label>92.</label>
<mixed-citation publication-type="journal"><string-name><surname>Velasquez</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ramezani</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Manal</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Raj</surname>
<given-names>D</given-names></string-name>. <article-title>Trimethylamine N-oxide: the good, the bad and the unknown</article-title>. <source/><italic toggle="yes">Toxins</italic>. <year>2016</year>;<volume>8</volume>(<issue>11</issue>):<fpage>326</fpage>. doi:<pub-id pub-id-type="doi">10.3390/toxins8110326</pub-id></mixed-citation>
</ref>
<ref id="cit0093">
<label>93.</label>
<mixed-citation publication-type="journal"><string-name><surname>Haghikia</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>XS</given-names></string-name>, <string-name><surname>Liman</surname>
<given-names>TG</given-names></string-name>, et al. <article-title>Gut microbiota–dependent trimethylamine N -oxide predicts risk of cardiovascular events in patients with stroke and is related to proinflammatory monocytes</article-title>. <source/><italic toggle="yes">Arterioscler Thromb Vasc Biol</italic>. <year>2018</year>;<volume>38</volume>(<issue>9</issue>):<fpage>2225</fpage>–<lpage>2235</lpage>. doi:<pub-id pub-id-type="doi">10.1161/ATVBAHA.118.311023</pub-id><pub-id pub-id-type="pmid">29976769</pub-id></mixed-citation>
</ref>
<ref id="cit0094">
<label>94.</label>
<mixed-citation publication-type="journal"><string-name><surname>Qi</surname>
<given-names>J</given-names></string-name>, <string-name><surname>You</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies</article-title>. <source/><italic toggle="yes">J Cell Mol Med</italic>. <year>2018</year>;<volume>22</volume>(<issue>1</issue>):<fpage>185</fpage>–<lpage>194</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jcmm.13307</pub-id><pub-id pub-id-type="pmid">28782886</pub-id></mixed-citation>
</ref>
<ref id="cit0095">
<label>95.</label>
<mixed-citation publication-type="journal"><string-name><surname>Roncal</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Martínez-Aguilar</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Orbe</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Trimethylamine-N-oxide (TMAO) predicts cardiovascular mortality in peripheral artery disease</article-title>. <source/><italic toggle="yes">Sci Rep</italic>. <year>2019</year>;<volume>9</volume>(<issue>1</issue>):<fpage>15580</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-019-52082-z</pub-id><pub-id pub-id-type="pmid">31666590</pub-id></mixed-citation>
</ref>
<ref id="cit0096">
<label>96.</label>
<mixed-citation publication-type="journal"><string-name><surname>Zhu</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Gregory</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Org</surname>
<given-names>E</given-names></string-name>, et al. <article-title>Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk</article-title>. <source/><italic toggle="yes">Cell</italic>. <year>2016</year>;<volume>165</volume>(<issue>1</issue>):<fpage>111</fpage>–<lpage>124</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2016.02.011</pub-id><pub-id pub-id-type="pmid">26972052</pub-id></mixed-citation>
</ref>
<ref id="cit0097">
<label>97.</label>
<mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Roberts</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Buffa</surname>
<given-names>JA</given-names></string-name>, et al. <article-title>Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis</article-title>. <source/><italic toggle="yes">Cell</italic>. <year>2015</year>;<volume>163</volume>(<issue>7</issue>):<fpage>1585</fpage>–<lpage>1595</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2015.11.055</pub-id><pub-id pub-id-type="pmid">26687352</pub-id></mixed-citation>
</ref>
<ref id="cit0098">
<label>98.</label>
<mixed-citation publication-type="journal"><string-name><surname>Rajilić-Stojanović</surname>
<given-names>M</given-names></string-name>, <string-name><surname>de Vos</surname>
<given-names>WM</given-names></string-name>. <article-title>The first 1000 cultured species of the human gastrointestinal microbiota</article-title>. <source/><italic toggle="yes">FEMS Microbiol Rev</italic>. <year>2014</year>. doi:<pub-id pub-id-type="doi">10.1111/1574-6976.12075</pub-id></mixed-citation>
</ref>
<ref id="cit0099">
<label>99.</label>
<mixed-citation publication-type="journal"><string-name><surname>Tang</surname>
<given-names>WHW</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Levison</surname>
<given-names>BS</given-names></string-name>, et al. <article-title>Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk</article-title>. <source/><italic toggle="yes">N Engl J Med</italic>. <year>2013</year>;<volume>368</volume>(<issue>17</issue>):<fpage>1575</fpage>–<lpage>1584</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa1109400</pub-id><pub-id pub-id-type="pmid">23614584</pub-id></mixed-citation>
</ref>
<ref id="cit0100">
<label>100.</label>
<mixed-citation publication-type="journal"><string-name><surname>Koeth</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Levison</surname>
<given-names>BS</given-names></string-name>, et al. <article-title>Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis</article-title>. <source/><italic toggle="yes">Nat Med</italic>. <year>2013</year>;<volume>19</volume>(<issue>5</issue>):<fpage>576</fpage>–<lpage>585</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nm.3145</pub-id><pub-id pub-id-type="pmid">23563705</pub-id></mixed-citation>
</ref>
<ref id="cit0101">
<label>101.</label>
<mixed-citation publication-type="journal"><string-name><surname>Hung</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kuo</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Tarng</surname>
<given-names>D-C</given-names></string-name>. <article-title>Indoxyl sulfate: a novel cardiovascular risk factor in chronic kidney disease</article-title>. <source/><italic toggle="yes">J Am Heart Assoc</italic>. <year>2017</year>;<volume>6</volume>(<issue>2</issue>):<fpage>102</fpage>–<lpage>110</lpage>. doi:<pub-id pub-id-type="doi">10.1161/JAHA.116.005022</pub-id></mixed-citation>
</ref>
<ref id="cit0102">
<label>102.</label>
<mixed-citation publication-type="journal"><string-name><surname>Karbowska</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kaminski</surname>
<given-names>TW</given-names></string-name>, <string-name><surname>Znorko</surname>
<given-names>B</given-names></string-name>, et al. <article-title>Indoxyl sulfate promotes arterial thrombosis in rat model via increased levels of complex TF/VII, PAI-1, platelet activation as well as decreased contents of SIRT1 and SIRT3</article-title>. <source/><italic toggle="yes">Front Physiol</italic>. <year>2018</year>;<volume>9</volume>. doi:<pub-id pub-id-type="doi">10.3389/fphys.2018.01623</pub-id></mixed-citation>
</ref>
<ref id="cit0103">
<label>103.</label>
<mixed-citation publication-type="journal"><string-name><surname>Dalager-Pedersen</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Søgaard</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Schønheyder</surname>
<given-names>HC</given-names></string-name>, <string-name><surname>Nielsen</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Thomsen</surname>
<given-names>RW</given-names></string-name>. <article-title>Risk for myocardial infarction and stroke after community-acquired bacteremia</article-title>. <source/><italic toggle="yes">Circulation</italic>. <year>2014</year>;<volume>129</volume>(<issue>13</issue>):<fpage>1387</fpage>–<lpage>1396</lpage>. doi:<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.113.006699</pub-id><pub-id pub-id-type="pmid">24523433</pub-id></mixed-citation>
</ref>
<ref id="cit0104">
<label>104.</label>
<mixed-citation publication-type="journal"><string-name><surname>Putot</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Chague</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Manckoundia</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Cottin</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zeller</surname>
<given-names>M</given-names></string-name>. <article-title>Post-infectious myocardial infarction: new insights for improved screening</article-title>. <source/><italic toggle="yes">J Clin Med</italic>. <year>2019</year>;<volume>8</volume>(<issue>6</issue>):<fpage>827</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jcm8060827</pub-id></mixed-citation>
</ref>
<ref id="cit0105">
<label>105.</label>
<mixed-citation publication-type="journal"><string-name><surname>Fugate</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Lyons</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Thakur</surname>
<given-names>KT</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>BR</given-names></string-name>, <string-name><surname>Hedley-Whyte</surname>
<given-names>ET</given-names></string-name>, <string-name><surname>Mateen</surname>
<given-names>FJ</given-names></string-name>. <article-title>Infectious causes of stroke</article-title>. <source/><italic toggle="yes">Lancet Infect Dis</italic>. <year>2014</year>;<volume>14</volume>(<issue>9</issue>):<fpage>869</fpage>–<lpage>880</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1473-3099(14)70755-8</pub-id><pub-id pub-id-type="pmid">24881525</pub-id></mixed-citation>
</ref>
<ref id="cit0106">
<label>106.</label>
<mixed-citation publication-type="journal"><string-name><surname>Roquer</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Cuadrado-Godia</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Giralt-Steinthauer</surname>
<given-names>E</given-names></string-name>, et al. <article-title>Previous infection and stroke: a prospective study</article-title>. <source/><italic toggle="yes">Cerebrovasc Dis</italic>. <year>2012</year>;<volume>33</volume>(<issue>4</issue>):<fpage>310</fpage>–<lpage>315</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000335306</pub-id><pub-id pub-id-type="pmid">22343923</pub-id></mixed-citation>
</ref>
<ref id="cit0107">
<label>107.</label>
<mixed-citation publication-type="journal"><string-name><surname>Tralhão</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Póvoa</surname>
<given-names>P</given-names></string-name>. <article-title>Cardiovascular events after community-acquired pneumonia: a global perspective with systematic review and meta-analysis of observational studies</article-title>. <source/><italic toggle="yes">J Clin Med</italic>. <year>2020</year>;<volume>9</volume>(<issue>2</issue>):<fpage>414</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jcm9020414</pub-id></mixed-citation>
</ref>
<ref id="cit0108">
<label>108.</label>
<mixed-citation publication-type="journal"><string-name><surname>Beynon</surname>
<given-names>RP</given-names></string-name>, <string-name><surname>Bahl</surname>
<given-names>VK</given-names></string-name>, <string-name><surname>Prendergast</surname>
<given-names>BD</given-names></string-name>. <article-title>Infective endocarditis</article-title>. <source/><italic toggle="yes">BMJ</italic>. <year>2006</year>;<volume>333</volume>(<issue>7563</issue>):<fpage>334</fpage>–<lpage>339</lpage>. doi:<pub-id pub-id-type="doi">10.1136/bmj.333.7563.334</pub-id><pub-id pub-id-type="pmid">16902214</pub-id></mixed-citation>
</ref>
<ref id="cit0109">
<label>109.</label>
<mixed-citation publication-type="journal"><string-name><surname>Musher</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Abers</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Corrales-Medina</surname>
<given-names>VF</given-names></string-name>. <article-title>Acute infection and myocardial infarction</article-title>. <source/><italic toggle="yes">N Engl J Med</italic>. <year>2019</year>;<volume>380</volume>(<issue>2</issue>):<fpage>171</fpage>–<lpage>176</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMra1808137</pub-id><pub-id pub-id-type="pmid">30625066</pub-id></mixed-citation>
</ref>
<ref id="cit0110">
<label>110.</label>
<mixed-citation publication-type="journal"><string-name><surname>Kastrup</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Boedicker</surname>
<given-names>JQ</given-names></string-name>, <string-name><surname>Pomerantsev</surname>
<given-names>AP</given-names></string-name>, et al. <article-title>Spatial localization of bacteria controls coagulation of human blood by ‘quorum acting‘</article-title>. <source/><italic toggle="yes">Nat Chem Biol</italic>. <year>2008</year>;<volume>4</volume>(<issue>12</issue>):<fpage>742</fpage>–<lpage>750</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nchembio.124</pub-id><pub-id pub-id-type="pmid">19031531</pub-id></mixed-citation>
</ref>
<ref id="cit0111">
<label>111.</label>
<mixed-citation publication-type="journal"><string-name><surname>Crary</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Buchanan</surname>
<given-names>GR</given-names></string-name>, <string-name><surname>Drake</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Journeycake</surname>
<given-names>JM</given-names></string-name>. <article-title>Venous thrombosis and thromboembolism in children with osteomyelitis</article-title>. <source/><italic toggle="yes">J Pediatr</italic>. <year>2006</year>;<volume>149</volume>(<issue>4</issue>):<fpage>537</fpage>–<lpage>541</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpeds.2006.06.067</pub-id><pub-id pub-id-type="pmid">17011328</pub-id></mixed-citation>
</ref>
<ref id="cit0112">
<label>112.</label>
<mixed-citation publication-type="journal"><string-name><surname>Gonzalez</surname>
<given-names>BE</given-names></string-name>, <string-name><surname>Teruya</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Mahoney</surname>
<given-names>DH</given-names></string-name>, et al. <article-title>Venous thrombosis associated with staphylococcal osteomyelitis in children</article-title>. <source/><italic toggle="yes">Pediatrics</italic>. <year>2006</year>;<volume>117</volume>(<issue>5</issue>):<fpage>1673</fpage>–<lpage>1679</lpage>. doi:<pub-id pub-id-type="doi">10.1542/peds.2005-2009</pub-id><pub-id pub-id-type="pmid">16651323</pub-id></mixed-citation>
</ref>
<ref id="cit0113">
<label>113.</label>
<mixed-citation publication-type="journal"><string-name><surname>Lee</surname>
<given-names>C-Y</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>Y-S</given-names></string-name>, <string-name><surname>Tsao</surname>
<given-names>P-C</given-names></string-name>, <string-name><surname>Jeng</surname>
<given-names>M-J</given-names></string-name>, <string-name><surname>Soong</surname>
<given-names>W-J</given-names></string-name>. <article-title>Musculoskeletal sepsis associated with deep vein thrombosis in a child</article-title>. <source/><italic toggle="yes">Pediatr Neonatol</italic>. <year>2016</year>;<volume>57</volume>(<issue>3</issue>):<fpage>244</fpage>–<lpage>247</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pedneo.2013.09.004</pub-id><pub-id pub-id-type="pmid">24279976</pub-id></mixed-citation>
</ref>
<ref id="cit0114">
<label>114.</label>
<mixed-citation publication-type="journal"><string-name><surname>Mantadakis</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Plessa</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Vouloumanou</surname>
<given-names>EK</given-names></string-name>, <string-name><surname>Michailidis</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Chatzimichael</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Falagas</surname>
<given-names>ME</given-names></string-name>. <article-title>Deep venous thrombosis in children with musculoskeletal infections: the clinical evidence</article-title>. <source/><italic toggle="yes">Int J Infect Dis</italic>. <year>2012</year>;<volume>16</volume>(<issue>4</issue>):<fpage>e236</fpage>–<lpage>e243</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijid.2011.12.012</pub-id><pub-id pub-id-type="pmid">22361432</pub-id></mixed-citation>
</ref>
<ref id="cit0115">
<label>115.</label>
<mixed-citation publication-type="journal"><string-name><surname>Arduini</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Zammit</surname>
<given-names>VA</given-names></string-name>, <string-name><surname>Bonomini</surname>
<given-names>M</given-names></string-name>. <article-title>Identification of trimethylamine N-oxide (TMAO)-producer phenotype is interesting, but is it helpful?</article-title>
<source/><italic toggle="yes">Gut</italic>. <year>2018</year>;<volume>2019</volume>. doi:<pub-id pub-id-type="doi">10.1136/gutjnl-2018-318000</pub-id></mixed-citation>
</ref>
<ref id="cit0116">
<label>116.</label>
<mixed-citation publication-type="journal"><string-name><surname>Vail</surname>
<given-names>GM</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>YJ</given-names></string-name>, <string-name><surname>Haney</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Barnes</surname>
<given-names>CJ</given-names></string-name>. <article-title>Biomarkers of thrombosis, fibrinolysis, and inflammation in patients with severe sepsis due to community-acquired pneumonia with and without Streptococcus pneumoniae</article-title>. <source/><italic toggle="yes">Infection</italic>. <year>2009</year>;<volume>37</volume>(<issue>4</issue>):<fpage>358</fpage>–<lpage>364</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s15010-008-8128-6</pub-id><pub-id pub-id-type="pmid">19169631</pub-id></mixed-citation>
</ref>
<ref id="cit0117">
<label>117.</label>
<mixed-citation publication-type="journal"><string-name><surname>Violi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Cangemi</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Calvieri</surname>
<given-names>C</given-names></string-name>. <article-title>Pneumonia, thrombosis and vascular disease</article-title>. <source/><italic toggle="yes">J Thromb Haemost</italic>. <year>2014</year>;<volume>12</volume>(<issue>9</issue>):<fpage>1391</fpage>–<lpage>1400</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jth.12646</pub-id><pub-id pub-id-type="pmid">24954194</pub-id></mixed-citation>
</ref>
<ref id="cit0118">
<label>118.</label>
<mixed-citation publication-type="journal"><string-name><surname>Johansson</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Shannon</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Rasmussen</surname>
<given-names>M</given-names></string-name>. <article-title>Platelet and neutrophil responses to Gram positive pathogens in patients with bacteremic infection</article-title>. <source/><italic toggle="yes">PLoS One</italic>. <year>2011</year>;<volume>6</volume>(<issue>11</issue>):<fpage>e26928</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0026928</pub-id><pub-id pub-id-type="pmid">22140434</pub-id></mixed-citation>
</ref>
<ref id="cit0119">
<label>119.</label>
<mixed-citation publication-type="journal"><string-name><surname>Andes</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Urban</surname>
<given-names>AW</given-names></string-name>, <string-name><surname>Acher</surname>
<given-names>CW</given-names></string-name>, <string-name><surname>Maki</surname>
<given-names>DG</given-names></string-name>. <article-title>Septic thrombosis of the basilic, axillary, and subclavian veins caused by a peripherally inserted central venous catheter</article-title>. <source/><italic toggle="yes">Am J Med</italic>. <year>1998</year>;<volume>105</volume>(<issue>5</issue>):<fpage>446</fpage>–<lpage>450</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0002-9343(98)00287-3</pub-id><pub-id pub-id-type="pmid">9831430</pub-id></mixed-citation>
</ref>
<ref id="cit0120">
<label>120.</label>
<mixed-citation publication-type="journal"><string-name><surname>Sato</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nakamura</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Fujita</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Peripheral venous catheter-related bloodstream infection is associated with severe complications and potential death: a retrospective observational study</article-title>. <source/><italic toggle="yes">BMC Infect Dis</italic>. <year>2017</year>;<volume>17</volume>(<issue>1</issue>):<fpage>434</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12879-017-2536-0</pub-id><pub-id pub-id-type="pmid">28623882</pub-id></mixed-citation>
</ref>
<ref id="cit0121">
<label>121.</label>
<mixed-citation publication-type="report"><collab>Denis Spelman, MBBS, FRACP, FRCPA M</collab>. <article-title>Suppurative (septic) thrombophlebitis</article-title>. <source/>Literature review current through. <year>2018</year>
<comment>Available from</comment>: <ext-link ext-link-type="uri" xlink:href="https://www.uptodate.com/contents/suppurative-septic-thrombophlebitis">https://www.uptodate.com/contents/suppurative-septic-thrombophlebitis</ext-link>.</mixed-citation>
</ref>
<ref id="cit0122">
<label>122.</label>
<mixed-citation publication-type="journal"><string-name><surname>Cox</surname>
<given-names>ER</given-names></string-name>, <string-name><surname>Amoroso</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gilliam</surname>
<given-names>BL</given-names></string-name>. <article-title>Pannus attack: septic thrombophlebitis</article-title>. <source/><italic toggle="yes">Am J Med</italic>. <year>2012</year>;<volume>125</volume>(<issue>12</issue>):<fpage>1175</fpage>–<lpage>1177</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.amjmed.2012.08.002</pub-id><pub-id pub-id-type="pmid">23062405</pub-id></mixed-citation>
</ref>
<ref id="cit0123">
<label>123.</label>
<mixed-citation publication-type="journal"><string-name><surname>Weinberg</surname>
<given-names>G</given-names></string-name>. <article-title>Upper-extremity suppurative thrombophlebitis and septic pulmonary emboli</article-title>. <source/><italic toggle="yes">JAMA</italic>. <year>1978</year>;<volume>240</volume>(<issue>14</issue>):<fpage>1519</fpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.1978.03290140061029</pub-id><pub-id pub-id-type="pmid">682360</pub-id></mixed-citation>
</ref>
<ref id="cit0124">
<label>124.</label>
<mixed-citation publication-type="journal"><string-name><surname>Xin Koh</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Kian Chng</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Guan Tan</surname>
<given-names>S</given-names></string-name>. <article-title>A rare case of septic deep vein thrombosis in the inferior vena cava and the left iliac vein in an intravenous drug abuser</article-title>. <source/><italic toggle="yes">Ann Vasc Dis</italic>. <year>2012</year>;<volume>5</volume>(<issue>3</issue>):<fpage>389</fpage>–<lpage>392</lpage>. doi:<pub-id pub-id-type="doi">10.3400/avd.cr.12.00036</pub-id><pub-id pub-id-type="pmid">23555542</pub-id></mixed-citation>
</ref>
<ref id="cit0125">
<label>125.</label>
<mixed-citation publication-type="journal"><string-name><surname>Cornford</surname>
<given-names>CS</given-names></string-name>, <string-name><surname>Mason</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Inns</surname>
<given-names>F</given-names></string-name>. <article-title>Deep vein thromboses in users of opioid drugs: incidence, prevalence, and risk factors</article-title>. <source/><italic toggle="yes">Br J Gen Pract</italic>. <year>2011</year>;<volume>61</volume>(<issue>593</issue>):<fpage>e781</fpage>–<lpage>e786</lpage>. doi:<pub-id pub-id-type="doi">10.3399/bjgp11X613115</pub-id><pub-id pub-id-type="pmid">22137414</pub-id></mixed-citation>
</ref>
<ref id="cit0126">
<label>126.</label>
<mixed-citation publication-type="journal"><string-name><surname>Kwiatkowska</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Knysz</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Gąsiorowski</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Witkiewicz</surname>
<given-names>W</given-names></string-name>. <article-title>Deep vein thrombosis of the lower limbs in intravenous drug users</article-title>. <source/><italic toggle="yes">Postepy Higieny I Medycyny Doswiadczalnej</italic>. <year>2015</year>;<volume>69</volume>:<fpage>510</fpage>–<lpage>520</lpage>. doi:<pub-id pub-id-type="doi">10.5604/17322693.1150215</pub-id><pub-id pub-id-type="pmid">25983290</pub-id></mixed-citation>
</ref>
<ref id="cit0127">
<label>127.</label>
<mixed-citation publication-type="journal"><string-name><surname>Antonova</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Zvetkova</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Ivanov</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Savov</surname>
<given-names>Y</given-names></string-name>. <article-title>Hemorheological changes and characteristic parameters derived from whole blood viscometry in chronic heroin addicts</article-title>. <source/><italic toggle="yes">Clin Hemorheol Microcirc</italic>. <year>2008</year>;<volume>39</volume>(<issue>1–4</issue>):<fpage>53</fpage>–<lpage>61</lpage>. doi:<pub-id pub-id-type="doi">10.3233/CH-2008-1068</pub-id><pub-id pub-id-type="pmid">18503110</pub-id></mixed-citation>
</ref>
<ref id="cit0128">
<label>128.</label>
<mixed-citation publication-type="journal"><string-name><surname>Huisjes</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bogdanova</surname>
<given-names>A</given-names></string-name>, <string-name><surname>van Solinge</surname>
<given-names>WW</given-names></string-name>, <string-name><surname>Schiffelers</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Kaestner</surname>
<given-names>L</given-names></string-name>, <string-name><surname>van Wijk</surname>
<given-names>R</given-names></string-name>. <article-title>Squeezing for life – properties of red blood cell deformability</article-title>. <source/><italic toggle="yes">Front Physiol</italic>. <year>2018</year>;<volume>9</volume>. doi:<pub-id pub-id-type="doi">10.3389/fphys.2018.00656</pub-id></mixed-citation>
</ref>
<ref id="cit0129">
<label>129.</label>
<mixed-citation publication-type="journal"><string-name><surname>Galante</surname>
<given-names>A</given-names></string-name>, <string-name><surname>DeLuca</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pietroiusti</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Effects of opiates on blood rheology</article-title>. <source/><italic toggle="yes">J Toxicol Clin Toxicol</italic>. <year>1994</year>;<volume>32</volume>(<issue>4</issue>):<fpage>411</fpage>–<lpage>417</lpage>. doi:<pub-id pub-id-type="doi">10.3109/15563659409011042</pub-id><pub-id pub-id-type="pmid">8057400</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>